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Goat anti-rabbit
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Genome negative
Genome positive
Human umbilical cord lymphocyte(s) 
Human peripheral blood lymphocyte(s) 
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Immunoglobulin
ImmunoglobulinsG, M,and A classes
Immunoglobulin k and X subclasses 
Infectious mononucleosis
Vsig, cl g surface Immunoglobulin, cytoplasmic
Immunoglobulin 
LCL Lymphoblastoid cell line
LMA Late membrane antigen
NPC Nasopharyngeal carcinoma
PAGE Polyacrylamide gel-electrophoresis
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QW EBV QIMR-WIL
RAH Rabbit anti-human
RAM Rabbit anti-mouse
Rb IgG Rabbit Immunoglobulin G
TCA Trichloroacetic acid.
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Summary
X X I
The aim of my studies for this thesis was to establish 
and characterize pairs of EBV-transformed lymphoblastoid 
cell lines (LCLs) which resulted from the transformation 
of human umbilical cord blood lymphocyte (HUCL) populations, 
by different strains of EBV. EBV-transformed human LCLs 
have been shown to represent bone marrow (B)-derived cell 
populations. Moreover, the immunoglobulin (ig) 
synthesizing cells vitro among LCLs are thought to 
represent populations of lymphocytes which had been 
synthesizing Ig vivo (Steel e_t , (1977)), LCLs 
are also thought to contain in their populations, other 
B-cell types. Finally, different strains of EBV are 
thought to have different biological characteristics 
in vitro. Two main premises to be tested were : - 
(l) strains of EBV have different 
characteristics iui vitro 
a nd
(11) EBV transforms both Ig as well as 
non-Ig synthesizing cells, that 
is, individual LCLs should represent 
different populations of Ig and non- 
Ig synthesizing cells vivo.
Each pair of cell lines was obtained from one common 
pool of HUCL population.
HUCL populations have been shown to be devoid of 
natural killer cells and EBV-specific cytotoxic thymus 
(T)-derived cells. This feature of HUCL populations,
renders them excellent tools for the, study of EBV-
XX 11
induced transformation vitro.
I established and characterized 16 pairs of LCLs.
One of two pools from each of 16 samples of HUCL 
populations was either EBV (B958) or EBV (QIMR-WIL) 
transformed. Transformed cells were characterized 
after the establishment of the transformed state as 
judged by acidity in the growth medium, coupled with the 
appearance of transformed foci of cells.
The time lapse between infection of HUCLs and the 
establishment of the transformed state was shorter among 
EBV (B958) than among EBV (QIMR-WIL) transformed cells.
The difference in the time lapse among the two groups of 
infected cells was attributable to differences in the 
transforming efficiences (TE). While EBV B958 had TE 
of 10^*^ transforming dose^^/ml (TD^^/ml), TE for EBV 
QIMR-WIL was found to be 10^"° TD^o/ml.
The higher TE for EBV B958 was attributed to the 
characteristic features of the virus and the B95S cells.
It was found that more than one EBV DNA core could become 
encapsidated in the EBV B958 capsid. This feature could 
contribute to the high transforming efficiency for EBV 
B958, B958 cells were found to survive for up to ten
days in culture without medium replenishment, and a high 
viability among the cell populations retained. On 
electron micrographs, encapsidated EBV B958 particles were 
seen attached to the surfaces of undisrupted B958 cells.
A cyclical phenomenon was proposed whereby, EBV B958
XXll 1
particles once released from disrupted cells, reinfect 
viable cells still in culture. The reinfected cells 
subsequently lysed and released viral particles, thus 
contributing to the maintenance of a high TE for EBV B958,
All 32 cell lines were found to synthesize the EBV- 
associated nuclear antigen, EBNA. There was no 
significant difference in the percentages of EBNA 
synthesizing cells between EBV (B958) and EBV (QIMR-WIL) 
transformed cells. However, EBV (B958) transformed cell 
lines were found to represent a higher number of producer 
cell lines than EBV (QIMR-WIL) transformed cell lines.
EBV (B958) transformed cell populations had higher 
percentages of Ig synthesizing cells than EBV (QIMR-WIL) 
transformed cell populations. EBV (B958) transformed 
cells had percentages of IgM and IgG synthesizing cells 
which were comparable to the percentages of IgM and IgG 
synthesizing cells among uninfected, untransformed HUCL 
populations. On the other hand, EBV (QIMR-WIL) trans­
formed cell populations had fewer Ig synthesizing cells 
than uninfected, untransformed HUCL populations.
Among long-term cultures of both EBV (B958) and EBV 
(QIMR-WIL) transformed cultures, populations of cells 
were selected for continual proliferation, which had 
higher percentages of EBV-associated early antigen 
positive (EA)* cells, than newly established cultures. 
Among these (EA)* cell populations, there was also 
increased percentages of cytoplasmic Ig positive cells.
It was therefore postulated that EBV-transformed cells
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in culture could proliferate and synthesize Ig as a 
direct response to EBV-associated antigenic stimulation.
One factor was very obvious among long-term cultures 
which were analyzed by SDS-polyacrylamide gel-electro- 
phoresis. Irrespective of the EBV strain which was 
used to induce transformation, the cells which survived in 
culture, were IgM synthesizing.
INTRODUCTION
ERRATUM
ECoR 1, read EcoR 1
1. EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES.
1.1. Burkitt's Lymphoma
In 1958, Dennis Burkitt found that a sarcoma of the 
jaws of African children was the most commonly occurring 
malignant tumour of African children who were attended to 
at the Mulago hospital in Uganda. He found that the tumour 
syndrome accounted for more than 50^ of all children's 
cancers which were seen in Uganda, and the sarcoma was 
distinctly associated with the cells of the lymphoid system. 
Later in 1962, he found that the disease was not any more 
common in males than in females. Nearly all cases which 
were recorded occurred Between the ages of 2 and I4 years, 
with a peak incidence at 5 years. The tumour syndrome was 
then referred to as Burkitt's lymphoma (BL).
One of Dennis Burkitt’s colleagues. Professor Davis, 
who was Based at the Makerere University in Uganda, 
suggested that the lymphoma could have Been associated with 
a virus. They took Biopsy cells from one such BL patient 
and dispatched these cells to M.A. Epstein _et a_l. , (England) 
who investigated them By electron microscopy. M.A. Epstein 
and Yvonne Barr (1964) found that the BL cells contained 
numerous Herpes-type virus particles which they referred to 
as Epstein-Barr virus (EBV), The event established the 
association of BL with EBV,
In 1976, G. Bornkamm jet aj.. , analyzed Biopsy cells 
which had Been taken from a European patient who had 
histologically typical BL, By nucleic acid hybridization with
EBV DNA, They found that the biopsy cells contained EBV 
DNAo Also in 1976, J.B, Ziegler _ejt aJL. , found that 20 
American patients who had BL, had serological profiles 
which were very similar to those of African patients,
BL can therefore occur as far afield as the United States, 
Europe, as well as Africa.
In 1970, P. Fia Ikow _et aU_. , looked at the genotype of 
normal and malignant tissue of seven patients who had BL 
and were heterozygous at the glucose-6-phosphate dehydrogen­
ase locus. They found that while two enzyme types were 
observed in normal tissue, only one enzyme type was found 
in each of the tumour cells which had been examined. In 
one -patient they found that four distinct tumours were found 
to have the same single cell type. This finding is indeed 
consistent with the hypothesis that individual BL tumours 
and perhaps the entire disease process has a clonal origin.
G. de The (1977) suggested that EBV could be reflective 
of an animal tumour virus whose oncogenic potential is 
enhanced by neonatal infection. R. Huebner jet , (1970)
found that the C-type RNA tumour virus genome of mice, 
chickens, hamsters and cats was most commonly transmitted 
vertically as part of the genetic inheritance of most, if not 
all cells. They suggested that the group-specific antigen 
and the tumour were independently determined and could thus 
be switched on independently but were also observed together. 
There is no evidence which would implicate a genetic 
inheritance for EBV. However, the fact that the expression 
of BL is confined to infants in particular and mainly
juveniles in general, would endorse the suggestion of
G. de The, that the development of EBV-oncogenesis could 
he associated with neonatal infection.
1,2. Infectious Mononucleosis
EBV is a ubiquitous virus as seen by its association 
with the internationally occurring, lymphoproliferative 
disease, infectious mononucleosis (IM). G . Henle _ejfc al., 
(1968) found that patients with IM regularly developed 
antibodies to EBV to acquire EBV seropositivity. The 
antibodies were distinct from the heterophile antibodies 
which are detectable in the acute phase of the disease.
They stipulated that either EBV or a closely affiliated 
agent was responsible for the expression of IM. To date, 
no other agent has been discovered which satisfies the 
criterion as closely as EBV, consequently, it is generally 
accepted that EBV is the causative agent which stimulates 
the pathological expression of IM.
I. Royston ejt aJ^ . , (1976) demonstrated that the 
peripheral blood lymphocytes (PBLs) which had been taken 
from IM patients were cytotoxic to bone marrow (B) derived but 
not to thymus (T) derived lymphqblastoid cell lines (LGLs),
They suggested that the usual self-limiting course of IM 
may relate to the immunological control mechanisms which 
normally regulate the proliferation of B-cells vivo.
D.J. Moss e_t 2^ ., (1978) obtained PBLs from donors who had 
developed antibodies to EBV, seropositive donors, exposed 
the cells to EBV and subsequently cultured the infected cells
at various densities. They found that cells which had been 
cultured at very high densities produced transformed foci 
of cells within the first two weeks of culture but there­
after regressed. Subcultures of cells which were made four 
weeks after infection, rarely, if ever, gave rise to LCLs. 
A„B. Rickenson _et , (1980) investigated the development
of EBV seropositivity among IM patients by the regression 
phenomenon. They found that there was development of a 
significant EBV-specific memory T-cell pool. EBV-specific 
memory T-cell activity was absent in the acute phase of IM, 
became evident at low levels 5-23 weeks after the onset of 
the disease and reached a maximum level after about 6 months, 
The development of EBV seropositivity in IM and among other 
seropositive donors is therefore dependent on the existence 
of a significant pool of EBV-specific memory T-cells.
1.3. Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPG). occurs in a markedly 
clustered geographical area. It is prevalent in Southern 
China, the adjacent Malaysian Archipelago, in a few small 
clusters of East Africa, Tunisia, and in some, additional 
parts of the world. It is commonly found in adults between 
the ages of 40 and 50 years old in an approximate ratio of 
2:1, males to females.
In animal species, the genes coding for molecules 
bearing various alloantigens which lead to rapid tissue 
graft rejection are located in the Major Histocompatibility 
Complex. In man, these genes coding for the alloantigens
are referred to as HLA and the genetic loci which are 
associated with their syntheses are : HLA-A, HLA-B,
HLA-C and HLA-D, M.J. Simons et. ? (1974) compared 
HLA profiles of predominantly Chinese patients with MFC, 
to those of suitably chosen controls. They found that 
there was a statistically significant elevation of the 
HLA haplotype, HLA-Az, among NFC patients.
To date, no data has been collated which would 
implicate a significant immunodef iciency or a genetic 
predisposition to EBV among BL and IM patients. On the 
other hand, among NFC patients there is a statistically 
significant probability that there may be a genetic 
predispositîon to EBV-induced oncogenesis.
2. THE DEVELOPMENT OF EBV-INDÏÏCED ONCOGENESIS IN VITRO.
2.1. Early Experiments On EBV-Induced Transformation jui vitro
During the earlier experiments on transformation of 
cells by EBV vitro, G . Henle e_t , (1967) lethally 
X-irradiated cells from two BL-derived LCLs, Jijoye and 
Raji. They then co-cultivated the X-irradiated cells 
with PBLs from a female infant. They found that the PBLs 
had been induced to proliferate, within 2-4 weeks when co­
cultured with Jijoye but not when co-cultured with Raji 
cells. They suggested that, present among the populations 
of Jijoye cells were EBV-carrying cells which could induce 
the transformation and subsequent continual proliferation 
of EBV-susceptible cells in vitro. Moreover, if either 
PBLs or the X-irradiated cells were cultured alone the
cells did not survive for any length of time. To support 
their claim to fame, they found that among 100-300 cells 
which were in the metaphase stage of chromosomal 
replication, none contained a Y-chromosome. Since Jijoye 
had been derived from a male patient, they concluded that 
the LCL had indeed been established from the PBLs of the 
female infant.
The discovery of G. Henle , (1967) strongly
points to the fact that, while some EBV-transformed LGLs 
carry infectious viral particles, others do not bear this 
characteristic. Since those early teething days of 1967, 
events have traversed a very long way in favour of the 
development of EBV-induced transformation vitro. 
Transformation in this context is, defined as : -
The morphological change in a
proportion of the Infected cells.
The event is associated with continual proliferation of the 
transformed cells, leading to the establishment of an EBV- 
transformed LCL.
2.2. Establishment of EBV-Trahsformed LCLs
Lymphoblastoid cell lines can be established from the 
tumour cells of NPC and BL patients as well as from the 
peripheral blood lymphocyte populations of IM patients.
LCLs can also be established from subjects with unrelated 
(in respect of the accepted EBV-associated) diseases.
M.A. Epstein e_t aj.., (1965) established BL-derived LCLs
from the biopsy cells of BL patients. J. Pagano et a l ..
(1976) successfully established EBV-infective LCLs from the 
PBLs of IM patients. In 1968, J.H. Pope established a 
LCL, QIMR-WIL, from the PBLs of a patient with myeloblastic 
le ukaemia.
2.3. Time Lapse Between Infection and Proliferation
The cultural environment does govern the successful 
establishment, of EBV-transformed LCLs. J.H, Pope (1968), 
and J.H. Pope a_l. ; (1974) found that the time lapse 
between infection of cells and the outgrowth of EBV- 
transformed foci of cells which subsequently led to the 
establishment of LCLs, varied between 5 and 35 days post 
infection. T. Katsuki _et , (1975) found that the time 
lapse which varied between 7 and 15.7 days was directly 
related to the titre of infectivity,
2.4. Classification of Lymphoblastoid Cell Lines
EBV-infected LCLs had been classified by G, Klein 
et al. , (1972) into two groups
1, Producers
2. Non-producers
These classifications have now been replaced by three terms
1. Restringent
2. Abortive
3. Productive
E. Kieff ejt a L . , (1979) have described these terms as
1. Restringently infected LCLs are cells 
which express the EBV-associated 
Nuclear Antigen (EBNA) and have an 
enhanced potential for continual 
proliferation vitro.
2. Abortively infected LCLs are 
restringently infected cells which 
have been induced to synthesize the 
EBV-associated antigens; membrane 
antigen, MA, and early antigen, EA.
The state of abortive infection can 
be brought about by the treatment of 
restringently infected cells with 
inhibitors of the cell cycle or by 
superinfection with extracellular virus. 
Abortively infected cells synthesize in 
addition to EBNA, MA, and EA and are 
associated with cellular RNA, DNA, and
■protein syntheses.
3. Productively infected LCLs (producers) 
express the additional EBV-determined 
virus capsid antigen, VCA.
The consequence of VCA production among a certain 
percentage of the producers, is the ultimate synthesis and/ 
or release of mature and/or infectious viral particles.
3. SYNTHESIS AND RELEASE OF VIRAL PARTICLES
G. Klein et. .Hi* ^ (1972) found that, among productively 
infected cells, only approximately 5^ of the cells in the 
population spontaneously entered the productive cycle.
About 2.5% of the cells which were found to be synthesizing 
the "early" products proceeded to the synthesis of the 
"late" products of the viral cycle, and < 2.5% released 
mature viral particles.
H. zur Hausen e_t a_l. , (1967), looked at the fate of
3 3H-Thymidine ( H-TdR) in productively and restringently
infected EB-3 and Raji cells respectively. Shortly after
3
a two hour pulse, H-TdR label as detected by autoradiography, 
could be seen in the nuclei of most EB-3 and Raji cells.
In a small fraction (approximately 5%) of EB-3 cells,
3
H-TdR label displayed a focal distribution which was 
sometimes detectable in the cytoplasms within eight.hours 
after the pulse. They compared their autoradiograms with 
EBV-specific immunofluorescence (IF), using human sera 
which contained antibodies to EBV-associated antigens.
They found that, most of the IF-positive cells displayed 
focal labelling when they were observed at 24 and 48 hours.
On the other hand, fewer cells were IF-positive and 
displayed focal labelling when they were observed at 8 
and 72 hours,
H. zur Hausen e_t al_., (1967.), suggested that there was 
a constant turnover of cells among producers, which 
synthesize products which are associated with the EB viral 
cycle. They found that all the individual fluorescent
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cells which had been picked, sectioned and observed by 
electron microscopy, contained numerous viral particles.
This finding led these workers to suggest that the cells 
which were synthesizing virally induced products were also 
synthesizing viral particles. The time between infection 
of cells and the subsequent release of EBV particles was 
approximated to be four days.
4. EPSTEIN-BARR VIRUS STRAINS
J.H. Pope (1968) found that QIMR-WIL was productive in 
favour of the release of infectious viral particles. The 
virus, EBV QIMR-WIL, has been used extensively by many 
workers including D.J. Moss at ^ . , (1972) and T. Katsuki 
et al., (1975) in their quest to elucidate EBV oncogenesis. 
Infectious virus has been recovered from the throat washings 
and epithelial tumour cells from NPC patients (C. Desgranges 
et a l . , 1977 and P.A. Trumper aL ., 1977) .
G. Miller ejb a L . , (1973) obtained a transforming strain 
of EBV from the IM-derived LCL, 883-L. They passaged EBV 
883-L in marmoset cells (B958) and obtained a transforming 
strain of EBV, EBV B958, which had a greatly increased 
titre when compared with EBV 883-L. They suggested that 
B958 could have facilitated the envelopment of a greater 
number of EBV particles than 883-L cells. The cultural 
conditions of producer cells does influence the acquisition 
of infectious virus particles.
It is very debatable whether or not EBV P^HR-1 does 
harbour transforming potential. T. Aya et al., (1974)
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reported on the successful transformation of human
umbilical cord blood lymphocytes (HUCLs) after infection
with EBV P^HR-1, J. Yata ejt a L . , (1975) suggested that
the former workers could have used an "early" passage of
the virus strain. EBV P^HR-1 was derived from Jijoye
cells as a subclone (G. Klein _et , 1979). W. Henle
et al., (1967) successfully transformed infant’s PBLs
after infection with X-irradiated Jijoye cells.
U. Schneider ejt a_l. , (1975) described the transforming
efficiency (TE) of a virus strain as the log^^ of the virus
dilution which induced 50% of replicate cultures (TD^^/ml)
to proliferate (i.e. TE = TD^^/ml). T. Sairenj et al.,
(1980), recently re-evaluated the transforming potential
of EBV Jijoye. They found that Jijoye when grown at a
"shift-down" temperature of 33°G, released infectious virus
5 2particles and TE was found to be 10 * TD^^/ml.
5. WHICH CELLS ARE SUSCEPTIBLE TO EBV-INDUCED
TRANSFORMATION IN VITRO ?
The question arises as to which cells are susceptible 
to EBV-induced transformation. The findings of P.A. Trumper 
et al., (1977) does implicate the susceptibility of the 
epithelial cells of NPC patients to EBV-induced trans­
formation. However, the findings of M.J. Simons _£t al., 
(1974) would suggest that the predisposition of NPC 
patients to EBV oncogenesis could be genetically determined 
in vivo.
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5.1, Surface Immunoglobulin Positive Cells and EBV 
Induced Transformation.
M. Jondal ejt aj.., (1973) obtained HUCLs, HPBLs, and 
EBV-transformed LCLs and exposed these cell populations to 
EBV receptor-positive cells, P^HR-1. They found that; 
HPBLs, HUCLs, and LCLs formed rosettes with P^HR-1 cells; 
suggesting that the lymphocyte populations bore EBV 
receptors. Moreover, when the cell populations were 
exposed to anti-immunoglobulin columns, they lost their 
capacity to form rosettes with P^HR-1 cells. The 
lymphocyte populations were also shown to bear receptors 
for complement and the crystallizable fragment (Fc) of 
immunoglobulin molecules. They suggested that surface 
immunoglobulin positive (slg^Fc**") B-cells, were indeed 
carriers of EBV receptors.
T. Katsuki e_t ad_. , (1977) separated HUCL populations 
into subpopulations of slg^Fc* (B)-cells, sig Fc*** (Null) 
cells, and T-cells, and exposed the different subpopulations 
of cells to EBV, They found that while T-cells and Null- 
cells were unsusceptible, slg^Fc^ (B)-cells were susceptible 
to EBV-induced transformation. Furthermore, the frequency 
of transformable cells correlated with the fraction of 
slg(M)-bearing cells. They suggested that slg(M)-bearing 
cells was the predominant subpopulation among HUCL 
populations which was susceptible to EBV-induced trans­
formation vitro.
M. Steinitz _^t a L . , (1980) preselected slg( A)-positive 
cells from the peripheral blood of human subjects and
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cervical lymph node lymphocytes of NPC patients. They 
successfully EBV-transformed the preselected lymphocytes.
T . Katsuki ejt a_l. ; (1975) exposed HUCL, to EBV B958 and 
EBV QIMR-WIL to obtain LCLs. Within five months of 
establishment, they subjected the LCLs to direct IF.
They found that the cell populations were sIgM-, and 
cytoplasmic (c)-IgG positive.
Thus, it does seem that, while slg(M)-bearing cells 
might be the predominant cell type among HUCLs which are
-f-
susceptible, other sIg cell types are susceptible to EBV- 
induced transformation vitro.
5.2. Macrophages and EBV-induced Transformation
J.H. Pope ejt aJ.., (1974) found that transformed foci 
of proliferating cells appeared in cultures of non-adherent 
cell populations from HPBLs when co-cultured with EBV 
QIMR-WIL, within 10-17 days of infection. When similar 
non-adherent cell densities were exposed to similar numbers 
of EBV QIMR-WIL particles in the presence of adherent cells, 
transformed foci appeared within 10 days of cultivation.
The adherent cells absorbed Indian ink, were slg^ and had 
the morphological appearance of, macrophages. They found 
that the non-adherent cells never developed transformed 
foci when they were freed of other cells and co-cultivated 
with EBV QIMR-WIL _in vitro.
U. Schneider ejt a L . , (1975) used TE to investigate the 
phenomenon of macrophage enhancement of EBV-induced trans­
formation of HUCLs. They found that TE was highest in
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unfractionated lymphocyte populations, reduced after 
macrophage depletion, and was reduced even further after 
B-cell depletion. When the different subpopulations were 
reconstituted, TE optimal was not attained in cultures with 
a high density of B-cells, but in cultures with a high 
density of macrophages. They suggested that there was a 
co-operative effect expressed when B-cells were co- 
cultured with macrophages and macrophages enhanced the 
proliferation of EBV-infected HUCLs vitro.
5.3. Human Fibroblasts and EBV-induced Transformation
J.H, Pope ejb , (1974) found that the transformation
of non-adherent subpopulations of cells from HPBL populations 
was inhibited when in culture with EBV QIMR-WIL and auto­
chthonous fibroblasts. D.J. Moss ^  a_l., (1977), 
investigated the phenomenon of "inhibition of EBV-induced 
transformation _in vitro" more closely. They co-cultured 
non-adherent cells from HUCLs or HPBLs (from seropositive 
and seronegative donors) with EBV QIMR-WIL and auto­
chthonous fibroblasts of either foetal or adult origin.
They found that transformation was inhibited only if the 
autochthonous fibroblasts were co-cultured with the non­
adherent cells which had been obtained from seropositive 
donors. They suggested that the autochthonous fibroblasts 
were not inhibitory to EBV-induced transformation _in vitro. 
The hypothesis which was put forward was that the fibroblasts 
supported the expression of inhibitory factor(s) which were 
present among the lymphocyte populations from seropositive 
donors.
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D.J. Moss 2^ a_l. , (1978) then attempted to test this 
hypothesis in their efforts to establish LCLs from HUCLs 
or HPBLs from seropositive and seronegative donors.
They found that, LCLs could not be established from the 
lymphocyte populations which had been obtained from sero­
positive donors. They separated and reconstituted 
lymphocyte subpopulations from seropositive donors. They 
found that LCLs could not be established only if T-cells 
were present in the cultures of HPBLs which had been 
obtained from seropositive donors.
5.4. Thymus-derived Cells and EBV-induced Transformation
E. Svedmyr _et , (1975) tested PBLs from IM patients 
and normal subjects, for their cytotoxic activity against 
EBV-genome positive lymphoblastoid cell lines (EBV-GP 
LCLs), or EBV-genome negative lymphoblastoid cell lines 
(EBV-GN LCLs), They found that unfractionated lymphocyte 
populations which had been obtained from IM patients and 
normal subjects were cytotoxic to EBV-GP LCLs as well as 
EBV-GN LCLs. , On removal of the cytotoxic lymphocytes 
which bore complement receptors (natural killer cells), 
from the lymphocyte populations of IM patients, the 
cytotoxicity was specific for EBV-GP LCLs, On the other 
hand, on removal of natural killer cells from the lymphocyte 
populations which had been obtained from normal subjects, 
the cytotoxic activity was completely obliterated. They 
suggested that lymphocyte populations from IM patients 
contained EBV-specific cytotoxic cells. These EBV-specific 
cytotoxic cells were not present in the lymphocyte
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populations of normal subjects,
T. Shope _et a_l. , (1979) separated T-cell populations
from neonates, seropositive and seronegative donors into ;
(l) subpopulations of T-cells which bore 
receptors for the Fc portion of IgG,
(T^) lymphocytes, 
and
(ll) subpopulations of T-cells which bore
receptors for the Fc portion of IgM (T^J 
lymphocytes,
They found that Tq lymphocytes which had been obtained from 
seropositive as well as seronegative donors, inhibited the 
outgrowth of autologous B-cells which had been exposed to 
EBV vitro. On the other hand, T^ lymphocytes and other 
T-cell subpopulations which had been obtained from neonates 
were not inhibitory to EBV-induced transformation vitro.
6. EXPRESSION AND CONTROL OF THE TRANSFORMED STATE
G. Miller e_t a L ., (1973) described EBV-induced trans­
formation i^ vitro as
- cell aggregation
- acid production
- increase in cell number
- acquisition by the culture, the 
capacity to be repeatedly subdivided.
- Cell aggregation was the state whereby cells
which had been transformed, replicated as clumps -
17
here it is noteworthy that BL-derived LCLs grow 
as single or small, loose clumps when in culture 
(K. Nilsson, 1978).
- Acid production was the state whereby there was 
a change in the pH of the growth medium from 
neutrality to acidity,
- Increase in cell number was the state whereby 
there was a significant increase in cell 
number as the transformed state was established.
- Acquisition by the culture to be repeatedly 
subdivided - as the transformed state was 
established the cells could be repeatedly 
subdivided and subcultured without loss of 
the characteristics of the transformed state.
6.1. Control of the Transformed State at the 
Transcriptional Level.
In cells which have been transformed by oncogenic 
viruses, a single gene or a small genetic region of the 
virus is sufficient to initiate and maintain the transformed 
state. Many viral mRNAs contain polyadenylic acid at their 
3 ’ termini which is thought to be associated with transport 
and stability of the RNA species. T. Orellana ^t al.,
(1977) analyzed the EBV-specific RNA in cultures of 
productively infected cells, B958, and HR-1, and 
restringently infected cells Namalwa, and Raji, by hybrid­
ization of cellular RNA with purified EBV DNA. They found 
that B958 and HR-1 contained viral RNA which was encoded
18
by approximately 45% of EBV DNA. Raji and Namalwa 
contained RNA which was encoded by approximately 30 and 16% 
of EBV DNA respectively. Almost all of the viral RNA 
species in B958 and HR-1 was found in the polyribosomal 
and polyadenylated RNA fractions. In Raji and Namalwa, 
the polyadenylated and polyribosomal viral RNA fractions 
were enriched for a class of EBV RNA which was encoded by 
approximately 5% of EBV DNA, The same EBV DNA sequences 
encoded the polyadenylated and polyribosomal fractions 
in both Raji and Namalwa, After superinfection of Raji 
cells with EBV HR-1, they found that abortively infected 
Raji contained RNA which was encoded by at least 41% of 
EBV DNA. The polyadenylated RNA of superinfected Ra-ji was 
enriched for a class of EBV RNA which was encoded by 
approximately 20% of EBV (HR-l) DNA. The polyadenylated 
RNA in superinfected Raji was encoded by the same DNA 
sequences which encoded the RNA species which was present 
in Raji before superinfection. They suggested that the
polyadenylated RNA and polyribosomal RNA fractions of 
restringently infected cells could be related to the 
maintenance of the transformed state.
N. Raab-Traub e_t a L . , (1978) analysed the restriction
endonuclease enzyme fragments of two transforming strains of 
EBV, EBV B958, and EBV W91, hnd a non-transforming EBV strain, 
EBV HR-1, They hybridized the DNA fragments of EBV B958,
EBV W91, and EBV HR-1 by hybridization blot experiments of 
the three EBV DNA species. They found that EBV (HR-l) DNA 
was missing DNA sequences which were contained in the ECoRl
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1-A, J through K and Hsu 1-B fragments of EBV (B958) DNA,
The fragments which were missing in EBV (HR-l) DNA, were 
common to both EBV (B958) DNA and EBV (W9l) DNA. They 
suggested that EBV (HR-l) DNA lacked the capacity to induce 
and maintain the transformed state due to the absence of 
the necessary "transforming" sequences.
6,2. Maintenance of the Transformed State at the 
Translational Level.
The entry of the transformed cell into the transformed 
state is associated with the detection of an Epstein-Barr 
Virus-associated Nuclear Antigen (EBNA). T. Aya _et al., 
(1974) found that among EBV-infected cells, EBNA was 
detectable within two days of infection. B. Reedman ejt a l . , 
(1973) found that EBNA was detectable by an anticomplementary 
immunofluorescence (ACIF) test among productively as well as 
restringently infected LCLs. J. Luka ^t a_l. , (1977) found 
that EBNA had a very strong affinity for double, as well as 
single stranded DNA. They suggested that EBNA may 
contribute to transformation by binding to DNA and thereby 
influence transcription and/or DNA replication. But,
D.L. Thorley-Lawson ejt a^., (1978) found that EBNA appeared 
on the DNA transcription machinery only when the cell and 
its DNA had entered the transformed state. When HPBLs 
were cultured with EBV B958 in the presence of 
phosphonoacetic acid, EBNA and cellular DNA synthesis 
occurred. On the other hand, neither EBNA nor cellular 
DNA synthesis occurred in the presence of cytosine 
arabinoside.
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A.T. Powell ejt , (1979) hybridized EBV (B95Ô) DNA 
which was homologous to Namalwa polyadenylated or non­
polyadenylate d RNA, to blots containing ECoR 1, Hsu 1, or 
ECoR l/Hsu 1 double cut fragments of EBV (B958) DNA or 
EBV (W91) DNA. They found that the viral polyadenylated 
RNA fractions from Namalwa cells was encoded by DNA which 
was contained primarily in the Hsu 1-A/ECoR 1-A and 
Hsu 1-B/ECoR 1-A fragments. The molecular weight of EBNA
Q
has been determined to be approximately 174 ^ 10 daltons.
The purified molecule has been found to dissociate into two 
components of 98 x 10 daltons each (Matsuo _et a L ., 1979 
and J. Luka et al., 1978). R . Pritchett _et a A . , (1975) 
found that the molecular weight of EBV DNA in producer cells 
was 1 X 10 daltons. T. Lindahl jet a A . , (1976) found that 
the EBV DNA in Raji had a molecular weight ‘ similar to 
that of the virus. A.T. Powell e_t a L . , (1979) have 
suggested that the transformed state could be maintained 
at the translational level. EBNA could be encoded by 
2 X 10^ daltons of EBV DNA.
6.3. Herpesvirus papio and EBV-associated Nuclear Antigen
L. Falk ejt £_1. , (1976, 1977) carried out hybridization 
experiments on Herpesvirus papio (HVP) with EBV-complementary 
RNA (cRNA). They found that EBV DNA and HVP DNA had 
40-50% homology. HVP-infected baboon lymphocytes had B-cell 
characteristics and sera from seropositive baboons had cross­
reactivity with sera from human EBV seropositive subjects. 
However, they could not detect a nuclear antigen in HVP-
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genome positive (GP) LCLs, situ. S. Ohno _et £l., (1977b) 
extracted nuclear fractions from HVP-GP LCLs. They added 
the nuclear extracts to methanol/acetic acid-fixed chicken 
red blood cells (CRBCs) or cells from EBV-GN LCLs, BJAB 
and Ramos. They found that a nuclear antigen could be 
detected in CRBCs, BJAB, and Ramos, by the acid-fixed 
nuclear-binding (AFNB) technique when coupled with ACIF.
S. Ohno ejt aJL. , (1978) found that there was an asymmetric 
cross-reactivity between human EBNA positive antisera and 
HVP nuclear antigen (HUPNA)-positive antisera. All the 
EBNA positive antisera reacted with nuclear extracts from 
productively and restringently infected HVP-GP LCLs.
On the other hand, none of the antisera which had been . 
obtained from baboons which were reactive in the AFNB 
technique for HUPNA, were reactive in the ACIF for EBNA 
when tested against EBV-GP LCL, Raji. Approximately half 
of the anti-HVP sera reacted with HUPNA.
G . Klein _et , (1978) superinfected BJAB and Ramos 
and the restringently infected HVP-GP LCL, 26CB-1, with 
EBV B958. They also superinfected Raji, BJAB and Ramos 
with HVP from the HVP, productively infected LCLs, 9B and 
18-C. They found that EBNA could be detected In 26CB-1, 
in situ and EA and VCA could be detected in Raji. EA 
could be induced in BJAB and 26CB-1, but EBNA could not be 
detected in Ramos, BJAB or 2ÔCB-1. They suggested that the 
lack of situ detection of a nuclear antigen among HVP- 
infected cells, was ' due to an innate inability of the 
virus to induce the synthesis of the nuclear antigen.
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Man and baboon are 20 x 10^ years apart. EBV and HVP 
could have originated from a common ancestor. If HVP
is the more primitive of the two virus strains, perhaps 
HVP-infected baboon cells can be transformed and the 
transformed state maintained without the continual synthesis 
of a virally induced product. On the other hand, it is 
probably essential that EBV-infected cells continually 
translate a virally induced product for the maintenance 
of the transformed state.
7. EBV-TRANSFQRMED HUMAN UMBILICAL CORD BLOOD LYMPHOCYTES
D.J. Moss £t al,., (1975) and T. Aya jet aJ^., (1974) 
found that EBV-transformed HPBLs and HUCLs produced EBNA 
but could not support the replication of other virally 
induced products, EA, MA and VCA. The inability of EBV- 
infected HUCLs to support the syntheses of most virally 
induced products is not known. However, the evidence is 
emerging that it could be associated with the number of 
EBV genome copies/cell (EBV GCs/C).
G. Klein et , (1976) EBV-couverted EBV-GN LCLs,
BJAB and Ramos into EBV-GP LCLs, BJAB (P^HR-1) and Ramos 
(P^HR-1), by superinfection with EBV P^HR-1. After 
induction of EA in BJAB (P^HR-l) and Ramos (P^HR-1) with 
5-iododeoxyuridine they found that the inducibility of EA 
varied among the converted lines. They suggested that there 
was a possible relationship between the susceptibility of 
cells to EA induction and the number of EBV GCs/C.
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K . Bister ^t a_l. ; (1979) treated clones of Raji cells 
which had various numbers of EBV GCs/C with 12-0-tetra- 
decanoylphorbol-13-acetate (TPA), They found that the 
susceptibility of clones to EA induction was dependent on 
the number of EBV GCs/C. Clones with a higher number of 
EBV GCs/C were more susceptible to EA induction by TPA, 
than clones with a lower number of EBV GGs/C. H. zur 
Hausen ejt a_l. , (1978) found that TPA efficiently induced 
the synthesis of EA and VGA in B958 and EA in Raji and 
NC^Y" On the other hand, EBV-transformed HUGLs were 
completely unsusceptible to either EA or VGA induction.
J. Hudewentz _et aj^ . , (1980) induced EA in Raji and then 
determined the amount of viral DNA/cell, by measuring the 
reassociation kinetics of labelled EBV DMA from virus 
particles, in the presence.of EBV DNA from Raji cells.
They found that the amount of EBV DNA/cell remained constant 
after EA induction by TPA. This suggested that TPA did 
not increase the amount of EBV DNA/cell among restringently 
infected cells. I. Ernberg _et aj_., (1977) determined the 
average number of EBV GGs/G by EBV-cRNA and measured the 
amount of EBNA/cell by quantitative immunofluorimetry,
They then compared the two parameters and found that the 
greater the number of EBV GGs/C, the greater the 
fluorescence intensity.
7,1. Epstein-Barr Virus Copies Per Cell
H. 2ur Hausen _et a^., (1972) found that the numbers of 
EBV GGs/C was a constant feature of EBV-GP LGLs. Although
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the numbers varied from one cell line to another, it 
remained constant for each cell line, between passages.
They found that the numbers varied between 3 and 200 for 
LGLs which had been established from NPC, BL, IM, and HPBL,
On the other hand, LGLs which had been established from 
HUGLs contained no complete EBV GG/G as determined by 
hybridization of EBV-cRNA. T. Lindahl ejt aJL. , (1974) 
found that African BL-derived LGLs contained between 10 
and 100 EBV GCs/C. J.S. Pagano ejt aj_. , (1976) found that 
LGLs which had been established from IM patients contained 
20 to53 EBV GG s/G while LGLs which had been established 
from HUGLs, contained only 10 to 13 EBV GGs/G.
7.2. IMMUNOGLOBULIN GLASSES, SUBCLASSES AND AGE
7.2.1. -Distribution of Subclasses Among Immunoglobulin 
Proteins.
L. Hood ^t aU^ . , (1967) obtained pools of sera which had 
been prepared from 20 different vertebrate species, and 
pools of human and murine myeloma proteins. Using gel- 
electrophoresis, they analyzed the distribution of kappa (k) 
and lambda (X) Ig subclasses among the different Ig protein 
fractions which had been obtained from the sera and myeloma 
samples. They found that the common (c) region of the Ig 
subclasses which had been obtained from closely related 
animals, were generally more similar in their amino acid 
sequences than those which had been obtained from distantly 
related animals. Among adult mice and humans, they found 
that the k : X ratios were 95 : 5% and 60 : 40^ respectively.
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They suggested an evolutionary relatedness between the 
genes which controlled the syntheses of Ig(k) subclasses 
among human and mice species. They found that 60% of the 
amino acid residues which had been obtained from human and 
mice, Ig(k), c-region proteins, were similar in their 
sequence distribution.
7.2.2. Immunoglobulin Subclasses Among Lymphocyte 
Populations
G. Haughton e_t , (1978) examined the distribution
of sig-positive cells among the lymphocyte populations of 
mice of varying ages by indirect IF. They prepared 
lymphocyte populations from the spleens, bone marrows, 
and livers. They found that foetal liver, bone marrow, 
and spleens contained sig-positive cells with a k : X ratio 
which approximated equality. -Among lymphocyte populations 
which had been obtained from adult spleens, there was a 
dominance of slg(k)-bearing cells over slg(X)-bearing cells. 
The dominance increased as a function of age. They 
hypothesised that the preponderance of slg(k)-positive cells 
in adult mice had been established by an antigen driven 
clonal expansion of the repertoire of Ig(k) genes which 
expanded as a function of age.
K.K. James e_t aG_. , (1974) found that the ratio of k : X 
Ig subclasses among the lymphocyte populations which had been 
obtained from children (< 10 yrs), approximated equality.
On the other hand, among the lymphocyte populations which 
had been obtained from human adult subjects, the number of
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slg(k)-bearing cells exceeded the number of sI g(X)-bearing 
cells in an approximate ratio of 2:1.
7.2.3. Immunoglobulin Classes Among Human Lymphocyte 
Populations.
P. Lobo e_t a U . , ( 1975) determined the %ages of slg-
positive cells among lymphocyte populations which had been 
obtained from human subjects. Among populations which had 
been obtained from the peripheral blood of 17 healthy adult 
subjects, they found that l8^ were slg^. However, this % 
age was reduced to 9 when the lymphocytes were pretreated 
by washing, followed by incubation at 37°C, prior to the 
IF test. This suggested that the lymphocyte populations 
from HPB contained an equal number of slg(^)^ and slg(y)^ 
cells.
S.E, Froland ejb aJL. , (1971) used antisera which had 
been prepared against the F(ab)2 fractions of the antibody 
molecules, to investigate the distribution of sig heavy 
chain classes among HPBL populations. They found that the 
%ages of slg(/i)’*’, 8lg(y)^, and slg(#)*, cells were;
6 (range 3-12), 5 (range 2-7), and < 1 respectively.
K.K. James _et aj.. , (1974) looked at the distribution of 
sIg heavy chain classes among lymphocyte populations which 
had been obtained from HPB and HUCB. Among HPBL populations 
of children (< 10 yrs), slg(p^* cells exceeded the number of 
slg(Y)* cells. Among HUCL populations which had been 
obtained from 12 subjects, the %ages of slg(^j* and 8lg(y)^ 
cells were 13 and 5-9 respectively. Among lymphocyte 
populations which had been obtained from adults, the ^ages 
of slg(^)* and slg/y)^ cells approximated equality.
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7.2.4. Lymphoblastoid Cell Lines : Immunoglobulin
Classes and Subclasses.
G.M. Steel ejt a_l. , (1977) investigated the phenomenon 
of Ig classes and subclasses by haemagglutination 
inhibition assay, in relation to EBV-transformed LGLs 
which had been established from HUGLs and HPBLs. They 
found that among EBV-transformed HUGLs, only Ig(pi) heavy 
chain class was secreted. On the other hand, among EBV- 
transformed HPBLs (adolescents and adults), Ig(^), Ig(y) 
and Ig(cv) heavy chain classes were secreted. While the 
ratios of k : X among LGLs (HUGLs), was 1:1, the ratios of
k : X among LGLs which had been established from HPBLs
were 1.4 : 1.0, and the ratios of Ig(ju) , Ig(y), Ig(a) among 
LGLs (HPB) were 2:1 : 0.5 respectively,
8. EPSTEIN-BARR VIRUS : SEROLOGY
8.1. The Acquisition of EBV Seropositivity
Most primary infections of EBV occur in childhood and 
early adolescence and are accompanied by permanent sero­
conversion (seropositivity) and life-long harbouring of the 
virus. The acquisition of EBV seropositivity during 
primary infections, confer permanent immunization against 
IM. EBV is transmitted vertically apd is expressive as 
IM mainly when contracted during late adolescence. The 
acquisition of EBV seropositivity does not necessarily 
lead to the expression of any EBV-associated disease.
W. Henle et al., (1970c) found that among patients who had
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undergone surgery with extracorporeal circulation with 
fresh blood and transfusions of stored blood, six without 
preoperative antibodies, developed antibodies to EBV 
without expressing any overt symptoms for NPC, IM or BL.
The titres and types of antibodies which are directed 
against the EBV-associated antigens, vary among seropositive 
subjects.
W, Henle et a_l. , (1970a) found that among NPC patients, 
there was a high titre of antibodies to MA, EA and VCA.
P. Gunven et aU., (1970) found that BL patients had elevated
titres to MA and VCA. I. Ernberg e_t aU., (1975) suggested 
that high titres to EA in long-term BL survivors, was 
indicative of tumour recurrence. W, Henle e_t a_l. , (1970b)
suggested that antibodies to EA possibly reflected current 
or recent disease processes which were associated with EBV.
V/. Henle _et , (1971) found that, seropositive subjects
who had recovered from IM had antibodies to MA, VGA, and 
EBNA, but not EA.
8.2. Antibodies to Early Antigen
G. Henle £_t al. , (1971) found that EA could be detected 
as two distinct forms in IF experiments. The restricted (R) 
form occurred as aggregates of varying sizes in the cytoplasms 
of infected cells. The diffused (D) form diffused throughout 
the nuclei and cytoplasms of infected cells and sometimes 
spread as a fluorescent component to adjacent cells in the 
smears, G. Henle _et a_l. , (1971); W. Henle ejt , (1971); 
and W. Henle ejt a U . , (1973) found that : about 70^ of IM
29
patients had antibodies to the (D) component of EA; and 
80^ of BL and NPC patients had anti-EA antibodies. While
anti-R was dominant in BL, anti-D was dominant in NPC 
patie nt8.
8 .3 . Membrane Antigen and the Viral Envelope
D. Silvestre e_t a U . , (1974) found that MA could be 
detected as two forms. Early membrane antigen (EMA) was
found to be an early, and late membrane antigen (LMA) was
found to be a late product of the EBV DNA synthetic 
machinery. Both EMA and LMA were found to be detectable 
on the viral envelopes as well as on the membranes of 
productively infected cells. " I. Ernberg. e_t a U . , (1975)
found that EMA and EBNA were the only EBV-associated antigens 
which were detectable among the tumour cells .which had been 
obtained from NPC and BL patients. L. Gergely e_t al. ,
(1971) suggested that the MA complex on the surfaces of
infected cells could represent viral envelope components 
which are inserted into the cell membranes. They found 
that exposure of ÉBV to sera with high anti-MA titres, 
neutralized the effects of the virus when judged by the 
inability of EBV (P^HR-1) to induce EA in Raji cells. The 
virus neutralizing titres could be reduced if the sera were 
preabsorbed with producer cells which had a high, but not 
with producer cells which had a low frequency of MA positive 
cells,
J.R. North aj_. , (1980) radioiodinated the MA complex
on the surfaces of B958, M-ABA, QIMR-WIL, and P^HR-1 producer
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cells. They analyzed the polypeptides which had been 
obtained, by immunoprécipitation of the MA-associated 
proteins and SDS-polyacrylamide gel-electrophoresis.
They compared their gel profiles from MA on the cell 
surfaces with gel profiles from the viral envelopes.
They found that MA appeared as a complex of four poly­
peptides both on the cell surfaces as well as on the viral 
envelopes. Additionally, they found that the two largest 
polypeptides showed minor differences in mobilities.
The differences were dependent on the origin of the virus 
strains i.e. whether they had been passaged in marmoset 
or human cells.
8.4. Rheumatoid Arthritis Nuclear Antigen (RANA)
M oA. Alspaugh ejb a_l. , (1978) found that sera which had 
been obtained from some rheumatoid arthritic (RA) patients, 
contained antibodies which had been directed against a 
nuclear antigen (Rheumatoid arthritis nuclear antigen) in 
producer cells,Wil^. They found that normal HPBLs did not 
contain Rheumatoid arthritis nuclear antigen (RANA), but 
after infection with EBV showed an increased frequency as 
the cells established the transformed state.
8.4.1. RANA and Epstein-Barr Virus Nuclear Antigen
T . Aya jet _al. , (1974) found that the frequency of EBNA 
positive cells increased as the cells established the 
transformed state. S. Slovin ejb a_l. , (1980) found that 
RANA could be detected in productively as well as
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restringently Infected cells Wil^ and Raji, B, Reedman 
et al., (1973) showed that EBNA could be detected in 
restringently as well as productively infected cells.
B. Reedman ejb aU_. , (1975) suggested that the low level of 
EBNA which is present among EBV-GP LGLs, precludes its 
detection by IF. M.A. Catalano _et a^ .. , (1979) observed 
that among RA patients, there was a higher than normal 
titre against EBNA. M.A. Alspaugh ejt , (1978) have
shown that RANA can be detected by IF. M.A. Alspaugh
et al., (1978) have suggested that the main component of 
the RA complex is IgG. A. Liabeuf e_t a_l* ^ (1975) found 
that the main component of anti-EBNA antisera which 
facilitates the detection of EBNA in ACIF, is IgG,
So Slovin ejt a_l. , (1980) found that in synchronized Raji 
and Wil^ cells, EBNA, and RANA could be detected at 
specific but close stages of the cell cycle. RANA 
reached a maximal level during early G^, declined during 
late G^, when EBNA was.at its maximal level. However,
RANA reappeared during late G^/M, when EBNA could not be 
detected.
One cannot therefore help the speculation on an 
association between the Rheumatoid arthritis nuclear antigen, 
EBNA, and their associations with Rheumatoid arthritis.
8.5. The Soluble (S) Antigen
V. Vonka ejt a_l. , (1970a) examined human sera for anti­
bodies to complement-fixing (CF) antigens which had been 
obtained from EBV-transformed LGLs, They investigated a
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soluble (S) antigen and a partially purified EBV particle 
(V) antigen from cell extracts. They compared two 
parameters; the CF assay, and the indirect EBV-specific 
IF. They found that all antisera which were reactive 
with the (S) antigen were also reactive with the (V) 
antigen. There was a high correlation between the CF-V 
antibody titre and the EBV-specific IF titre with producer 
cell line EB-3. Many CF-S antibody negative antisera had 
high CF-V antibody titre. They suggested that the antigens 
which were detectable by EBV specific IF and the CF-V 
antigens, were closely related. On the other hand, the 
CF-S antigen was immunologically distinct,
8.5.1. (S) and Epstein-Barr Virus Nuclear Antigen
V. Vonka e_t aj.., (1970b) found that cellular extracts 
which had been derived from restringently as well as 
productively infected cells contained the (S) antigen.
B. Reedman e^ a^., (1973) suggested that (S) and EBNA 
could be related,
G. Lenior e_t a_l., (1976) characterized (S) which had 
been obtained as cellular extracts from Raji, by sucrose 
gradient centrifugation, gel filtration, and ion exchange 
chromatography. They found that (8) had a molecular weight
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of 180 X 10 daltons and fractions which contained (S), 
inhibited the ACIF test for EBNA. J. Luka £t , (1978) 
purified EBNA from cellular extracts of Raji, B958, and 
Namalwa, by DNA-cellulose chromatography, hydroxyapatite
chromatography and gel filtration. They found that, all
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EBNA preparations inhibited the ACIF test for EBNA when 
coupled with the complement fixation assay for (S),
The cellular extracts bound to methanol/acetic acid-fixed
(AFNB) metaphase chromosomes. The purified extract had a
3 3molecular weight of 170 x 10 to 200 x 10 daltons.
S. Ohno ejt a_l. , ( 1977a) extracted, purified (S) by 
DNA-cellulose chromatography, and combined AFNB with ACIF. 
They found that a brilliant nuclear staining, characteristic 
of EBNA, could be detected. The purified antigen was 
found to have a molecular weight of 174 (- 15) x 10^ daltons, 
as determined by sucrose gradient centrifugation and gel 
filtration experiments. They suggested that (S) and EBNA 
were identical.
9. THE EPSTEIN-BARR VIRUS DNA
9.1. EBV DNA In Producer Cells.
Do Given aj_. , (1978) determined the arrangements of 
restriction endonuclease cleavage sites of EBV (B958) DNA, 
EBV (W91) DNA and EBV (HR-l) DNA. They used ECoR 1, Hsu 1 
and Sal 1 to determine the sizes and homologous sequences 
of the EBV DNAs. They used EBV (B958) DNA (Fig, 1) as 
the prototype to relate their findings to EBV (W9l) DNA 
and EBV (HR-l) DNA.
They found that the sizes of almost all the ECoR 1,
Hsu 1 and Sal 1 fragments of EBV (W9l) DNA and EBV (B958)
DNA were identical. A single ECoR 1 fragment, ECoR 1-C, 
was approximately 7 Megadaltons (MDs) larger than the ECoR
1-C fragment of EBV (B958) DNA. On digestion of the region
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of EBV (W9l) DNA which corresponded to ECoR 1-C with Hsu 1 
or Sal 1, they obtained two fragments; Hsu 1 (D^/D^) and 
Sal 1 (G^/G^). The total sizes of Hsu 1 (D^/D^) or Sal 1 
(G^/G^) was 7 MDs larger than the ECoR 1-C fragment from 
EBV (B958) DNA. They labelled EBV (HR-l) DNA and removed 
the sequences which were homologous to EBV (B958) DNA.
They found that the ECoR 1-C fragment of EBV (HR-l) DNA 
was similar in size to the ECoR 1-C or Hsu 1 (D^/D^) frag­
ments of EBV (W91) DNA. The ECoR 1-C fragment of EBV 
(Jijoye) DNA was approximately 7 MDs larger than the ECoR 
1-G fragment of EBV (B958) DNA and was identical in size to 
the ECoR 1-C fragment of EBV (W9l) DNA. They implicated a 
similarity in structure and sequence between EBV (HR-l),
EBV (W9l), and EBV (Jijoye) DNAs. They suggested that the 
similarity between the "extra” EBV DNA which had been found 
in EBV (HR-l) DNA, EBV (W9l) DNA and EBV (jijoye) DNA could 
reflect a characteristic sequence and structure of BL-derived 
EBV strains,
9.2. Sequence Variability Among EBV DNAs
E. Henderson ejt , (1977) found that the frequency 
of transformation of. HPBLs was 100 times less sensitive, 
and lymphocytes which had been obtained from the peripheral 
blood of marmosets was 1,000 times less sensitive, than 
HUCLs to EBV B958-induced transformation. L. Rymo _ejt al., 
(1979) used the restriction endonuclease enzyme ECoR 1 to 
fragment intracellular EBV DNAs from 2 3 different isolates 
of LGLs which had been established from ; HUCLs, HPBLs,
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BL, NPC and IM subjects. They found that sequence 
variability among the different DNA isolates was largely 
confined to the ECoR 1-C, -A, and -I fragments when 
they related their fragment analysis to EBV (B958) DNA 
linkage map, Fig. 1. They found that EBV (8B3-L) DNA 
was completely devoid of the ECoR 1-C fragment. They 
suggested that, the possibility could not be eliminated 
that, a small, variable region of host DNA may be included 
in the ECoR 1-C fragment of intracellular EBV DNA.
9.2.1. Amplification of EBV DNA
B. Sugden e_t a_l. , (1979) infected HPBLs with 0,02 to
0.10 EBV (B958) DNA particles/cell and immediately cloned 
the cells in agarose. They found that within 30 generat­
ions, all the transformed clones contained between 5-800 
EBV GCs/C. They related the amount of intracellular EBV 
DNA, X, to the number of EBV GCs/C, Y. They found that 
the greater the value of X, the higher the value of Y .
They suggested that EBV DNA could have undergone 
amplification (relative to cellular DNA) after trans­
formation had occurred.
If amplification of EBV DNA does occur (relative to 
cellular DNA) in transformed cells, it is conceivable that 
the heterogeneity of the ECoR 1-A, -C, and -I, could be 
realized.
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9.3. Circular EBV DNA
M, Nonoyama , (1972) found that although the EBV
DNA in Raji cells was detected within the cellular chromo­
somes, EBV DNA could be separated from cellular DNA on 
alkaline sucrose gradients, as complete, or nearly complete 
strands. They suggested that EBV DNA in restringently 
infected cells was not bound to chromosomal DNA as 
integrated sequences, but existed as unintegrated replicons, 
A. Adams H i *j (1973) partly agreed with the findings of 
M. Nonoyama e_t aj.,, but they found that a fraction of EBV 
DNA in Raji could not be separated from cellular DNA in 
neutral glycerol gradients. A. Tanaka e_l ; (1974) 
found that 80-90% of EBV DNA in Raji was not integrated but 
10-20% remained bound to cellular DNA. The unintegrated, 
purified, EBV DNA had a density of 1.716 - 1.717 gm/cm^ 
as determined by caesium chloride equilibrium centrifugation.
A. Adams ejt aj.., (1975) coupled sedimentation analysis on 
neutral glycerol gradients by hybridization experiments 
using EBV-cRNA. They recovered two distinct species of 
DNA which sedimented at rates of 1.70 - 1.75 and 1,10 - 
1.12 times as fast as linear EBV DNA from producers.
They suggested that the intracellular EBV DNA in Raji had 
the hydrodynamic properties of a covalently closed, circular, 
and a nicked, (containing single strand breaks) circular ' 
form. The intracellular EBV DNA in Raji could therefore 
replicate as integrated, as well as an unintegrated 
molecule.
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B. Hampar e_t a_l. , (1974) found that the circular EBV 
DNA in Raji cells replicated only during the early synthetic 
(S^) phase of the cell cycle, suggesting that the replication 
of the EBV (circular) DNA is Indeed entwined with the 
synthesis of cellular DNA. C. Kintner e_t aj_. , (1979) 
digested EBV (B958) DNA with X-exonuclease and found that 
the DNA molecule, upon reannealing formed full length 
circles. They suggested that the viral DNA could contain 
repeat sequences at its termini which permitted the 
circularization of the molecule.
MATERIALS
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1. Fine Chemicals
The following chemicals were supplied as indicated : -
Fluorescein isothioc'yanate 
(FITC), Isomer I.
Tris (hydroxymethyl)
aminoethane (Trizma base) 
Triton X-100, purified
N N •-methylene bisacrylamide
Heparin, preservative free
Giemsa staining solution
Evan's blue, dry powder 
Trypan blue, dry powder 
DPX mounting medium
Ficoll 400 
Sodium hypaque
Sigma (U.K.) Ltd. , 
London, England.
Koch-Light Labs. Ltd., 
Colnbrook, England. 
Eastman Kodak Co., 
Rochester, New York. 
Evan's Medical Ltd., 
Liverpool, England. 
Gurr Products,
Suffolk, England.
12, The Viaduct, 
Middlesex, England. 
Pharmacia Fine Chemicals, 
Sweden,
Winthrop Labs.,
Surrey, England.
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2. Cell Culture Materials
The following cell culture materials were supplied
by : -
Gibco-bio-Cult (Europe) Ltd., Washington Road, 
Paisley, Scotland.
RPMI-I64O, dry powder 
Foetal calf serum
Screw-capped (10 ml) plastic tubes
2 2Falcon tissue culture flasks (25 cm , 75 cm ) 
and -petri dishes (50 mm in dia.).
Freeze-dried stocks of streptomycin sulphate and benzyl 
penicillin were supplied by : -
Glaxo Pharmaceuticals, London, England.
Glass test tubes, and pipettes were supplied by : - 
Corning Glass Works, Corning, New York, U.S.A.
3. Radiochemicals.
The following^ radiochemicals were supplied by : - 
The Radiochemical Centre, Amersham, England.
Amino Acids Specific Activity
L-[4, 5-^H] leucine 61 Ci/mMole
L-^^sj methionine 1,280 Ci/mMole
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4. Photographic and Liquid Scintillation Spectrometry 
Materials
The following materials were supplied as indicated : -
Ektachrome 4OO film
Ektachrome 50 film 
(Tungsten Grade)
X-Omat H film, 24 x 30 cm 
DX-80 Developer 
EX-40 X-Ray Liquid Fixer 
Lightproof vinyl film bags
2,5 Diphenyloxazole (PPO)
Transparencies from 
Ektachrome 4OO and 50
Kodak (U.K.) Ltd., 
London, England.
H.A. West (X-Ray) Ltd., 
Edinburgh, Scotland, 
Koch-Light Labs. Ltd., 
Colnbrook, England.
Brian and Spears Colour 
Labs., Glasgow, Scotland
Other materials not mentioned above, were supplied by 
BDH Chemicals Ltd., Poole, Dorset, England.
5. Lymphoblastoid Cell Lines
The following lymphoblastoid cell lines were obtains 
as a kind gift from : -
Dr. G.B, elements, Institute of Virology,
University of Glasgow.
Bec-11, Daudi, B958, QIMR-WIL, Raji (6HAT25DC)
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6 . Laboratory Bred Animals
Mice (Balb/c) were bred in the animal colony of 
The Biochemistry Department, University of Glasgow, by 
brother/sister (F^) matings.
7. Antisera and Antibody Preparations
The following antisera which were raised against human 
immunoglobulins were supplied as indicated : -
Behring Hoechst Pharmaceuticals, 
Hoechst House, Hounslow, England
FITC-conjugated Rabbit 
anti-IgM (^-specific)
FITC-conjugated Rabbit "
anti-IgG (y-specific)
FITC-conjugated Rabbit "
anti-X (Bence Jones Protein)
FITC-conjugated Rabbit ”
anti-k (Bence Jones Protein)
Rabbit anti-IgG (y-specific) Miles Labs,, Research Products
Ltd., Slough, England,
Rabbit anti-k "
(Bence Jones Protein)
Rabbit anti-X "
(Bence Jones Protein)
Rabbit IgG (Rb IgG) Nordic Immunological Labs,
Ltd., Berks., England.
Human antisera which contained antibodies directed 
against EBV-associated antigens were obtained as a gift
from : -
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Dr. George Klein, Karolinska Institute!,
Stockholm, Sweden.
The relevant information related to the special 
features of anti-EBV antisera is displayed in Table 1.
In addition, various antibody preparations (Section 10, 
Methods) were derived by : -
Mrs E. Blakeley, Biochemistry Department,
University of Glasgow.
8. Chromatography and Other Materials
Sepharose 4B Pharmacia (GB) Ltd.,
London, England.
Sephadex; G-200, G-lOO, A - 50 "
Cytocentrifuge papers Shandon Ltd.,
Camberley, England.
Microscope glass slides Chance (Propper) Ltd.,
and coverslips Warley, England.
Millipore filters Millipore (U.K.) Ltd.,
London, England.
Amicon filters Amicon Corporation,
Lexington, Mass., U.S.A.
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Table 1. Characteristics of Human anti-EBV Antisera
Designation
EA
D R
Antigen Titre
VCA EBNA
*IF
Reactivity
Ingela <10 <10 <10 <10 EBNA“
Ingemar <10 <10 <10 <10 EBNA"
Eva Klein <10 <10 <10 <10 C '
Walter Owino 40 320 320 160 EBNA^
F^y^-Esther 2560 ND 5120 ND (EA /VG A)*
F^-Katana - - 640 ND VCA^
Abbreviations : ^1’ F = FITC conjugate 4
number
•X-
- f
I
= Negative , Positive, Complement
ND = Not done.
METHODS
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1. STOCK SOLUTIONS
1,1. Cell Culture Medium
The components of RPMI-I64O (the cell culture medium 
which was used throughout this work), are displayed in 
Table 1. The solution was prepared from the dry powder 
in deionised water and the pH monitored to 7.0 with 
concentrated HCl. The medium was sterilized by Millipore 
filtration (pore size, 0.22 /jm) and stored at 4°0. The 
complete medium (CM) was prepared according to the following 
formulation : -
Complete Medium
RPMI-I64O. 90% (by volume)
Foetal calf serum (FCS) 10% (by volume)
Benzyl penicillin 100 i.u./ml
Streptomycin sulphate 100 ^ g/ml
L-glutamine 0.3 mg/ml
The components of complement in FCS were inactivated 
by heating the FCS at 56°C for 30 mins.
Stock solutions (XIO) of benzyl penicillin/streptomycin 
sulphate, and L-glutamine were stored at -20^C.
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Table 1 Composition of ,RPMI-l64Q Cell Culture Medium
Amino Acids mg/l
L-arginine 200.00
L-asparagin H^O 56.82
L-aspartic acid 20.00
L-cysteine, disodium sait 59.15
L-glutamic acid 20.00
L “glutamine 3 00.00
glycine 10.00
L-histidine 15.00
L-hydroxyproline 2 0.00
L-isoleuc ine 50.00
L-lysine HCl 40.00
L-leuc ine 50.00
L-methionine 15.00
L"phenylalanine 15.00
L-proline 2 0.00
L-serine 30. 00
L-threonine 20.00
L-tryptophan 5.00
L-tyrosine 2 0.00
L-valine 20.00
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Table 1 (contd.)
Vitamins mg/l
Biotin 0.20
D-calcinm pantothenate 0,25
Choline chloride * 3.00
Folic acid 1.00
i-Inositol 35.00
Nicotinamide 1.00
p-Aminobenzoic acid 1,00
Pyridoxine HCl 1.00
Riboflavin 0,20
Thiamin HCl 1.00
Vitamin 0.005
Inorganic Salts
Calcium nitrate ' 69.49
'Potassium chloride 400,00
Magnesium sulphate 100.00
Sodium chloride 6,000.00
^Sodium bicarbonate (NaHCO^) 2,000,00
di-Sodium hydrogen phosphate 800,00
Other Components
Glucose 2,000.00
Glutathione 1.00
Sodium phenol red 5.00
* NaHCO^ (dry powder) was added to the dissolved RPMI-I64O
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1,2. Phosphate Buffered Saline, pH 7.2
Phosphate buffered saline (PBS-A) consisted of : -
g/l
Sodium chloride 10.00
Potassium chloride 0.25
di-Sodium hydrogen
orthophosphate 1.44
Potassium di-hydrogen
orthophosphate 0,25
The solution was stored at room temperature.
2. GENERAL METHODS
2.1. Preparation of Smears : Cytocentrifugation
Cytocentrifuge papers were aligned with microscope 
glass slides (76 x 26 mm) and cytocentrifuge buckets, in 
the Shandon cytocentrifuge. Cells were washed in, and 
resuspended in, PBS-A, Aliquots (500 ^l) were placed in 
the buckets and smears (4-5 x 10^ cells) prepared by 
centrifugation at 170 xg for 10 mins. The smears were air- 
dried and fixed,
2.2. Trypan Blue Exclusion Test
Any clumps of cells which were in the samples of cell 
suspensions were completely disrupted. Cell suspensions 
were added to equal volumes (200 jLil) of Trypan blue solution, 
final concentration 0.005% w/v in PBS-A.
49
Trypan Blue Staining Solution
Trypan blue (dry powder) was 
dissolved (0.01% w/v) in PBS-A.
The suspensions of cells were left at room temperature 
for 10 mins. Viable cells excluded, nonviable cells 
incorporated the Trypan blue solution. The total number 
of cells was counted in a Neubauer type hemocytometer and 
the %age viability of the cell suspensions determined as 
follows : -
%age viability = Mo. viable cells ^
Total No. of cells
2.3. Giemsa's Staining Technique
All steps were carried out at room temperature.
Cell smears were prepared by cytocentrifugation and fixed 
in methanol for 10 mins. The smears were washed in 
distilled water and then emersed in Giemsa's staining 
solution.
Giemsa's Staining Solution 
50% (v/v) of stock solution 
in distilled water.
The smears were left for 20 mins, decolourised in 
acetic acid (1% v/v)/in distilled water for 5-10 mins, 
dehydrated in methylated spirit for approximately 5 mins 
and in absolute alcohol for a further 5 mins. The smears 
were emersed in two separate changes of xylene (5-10 rains) 
and mounted in DPX mounting medium with glass coverslips
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(13 mm in dia.). Smears were observed by ordinary light 
microscopy, using Leitz Ordinary Light Microscope and 
photographed when necessary, with Ektachrome 50 (Tungsten 
grade).
2.4. Acquisition of Newborn Mice (J, Ebling jet aj.. , 1971)
Platinum loops were sterilized by flame and cooled in 
clean water. The loops were inserted into the vaginal 
passages of mice and contents of the vagina placed on 
microscope glass slides. Using ordinary light microscopy, 
the vaginal smears were examined for the presence of 
nucleated epithelial cells which signified the pro-oestrus 
stage of the oestrus cycle. Mice which were in the pro­
oestrus stage were mated, and litters (4-6 mice) obtained 
19-25 days after mating. Single cell suspensions were 
prepared from the livers and spleens of mice which were 
<24 hr8 old.
3. Preparation of EB Virus Suspensions (T. Katsuki
et al., 1975 and U, Schneider ^  , 1975)
The viability of cultures from 3 day-old cultures of
B958 or Q,IMR-WIL producer cell lines was determined by
the Trypan blue exclusion test. Cells from cultures
which were >90% viable were suspended in CM (3-4 % 10
cells/ml). The cells were incubated at 37^0 for 9 days 
2
in 75 cm tissue culture flasks. Supernatants from a 
total volume of 3 litres of culture was collected by 
centrifugation at 450 xg for 40 mins. The cell-free
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extracts from B958 (EBY B958) or QIMR-WIL (EBV QIMR-WIL) 
were twice frozen and thawed, and centrifuged at 450 xg 
for 20 mins. EBV B958 and EBV QIMR-WIL were filtered 
hy Millipore filtration (pore size, 0.8 fxm in dia.) to 
purify the extracts and stocks stored at -70°G in aliquots 
of 2.0 mis.
4. ELECTRON MICROSCOPY
4.1. Fixation of Cells
Cell suspensions from 9 day-old cultures of B958 or
QIMR-WIL producer cell lines were centrifuged at 350 xg
for 30 mins, Gluteraldehyde solution in Sorensen's 
phosphate buffer (SPB) was added and the cells incubated 
at 4°C for 24 hrs.
Sorensen's Phosphate Buffer, pH 7.38 
Sodium phosphate dibasic 20% (v/v)
(0.947% w/v)
Potassium acid phosphate 80% (v/v)
(0.907% w/v)
2% Gluteraldehyde Solution in SPB 
Gluteraldehyde stock solution 8 ml
SPB 92 ml
The cells were then washed in three separate changes 
of SPB for 20 mins each wash, at 4°^. Cells were "post - 
osmicated" by the addition of osmium tetroxide for 45 mins
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Osmium Tetroxide in SPB 
Equal parts of Osmium tetroxide 
(2% in distilled water) and SPB.
The cells were washed in three separate changes of 
SPB for 20 mins each wash, then dehydrated,
4.2, Dehydration of Cells
The cells were processed in the following solutions 
(1.0 ml) as indicated : -
Dehydrating Solution Time (Mins)
Ethyl alcohol 2 5% (v/v) 10
" ” 50% (v/v) 10
" " 7 5% (v/v) 10
Absolute a l c o h o l  1 30
” "  2 30
I M ----- 3 30
'« " ----- 4 30
Propylene oxide -----1 10
" "  2 10
Araldite mixture (l.O ml) was added to the cells, 
and then left at room temperature for 2 hrs. Equal parts 
of Araldite mixture was then added, to give a total con­
centration of 3 parts Araldite mixture to 1 part
Propylene o x i d e  2. The cells were left at room
temperature for 2 hrs, and washed in Araldite mixture.
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Araldite Mixture
Araldite resin (CY 212) 
Dodecenylsuccrinic anhydride 
Dihutyl phtholate 
2,4,6-tri(dimethylaminoethyl) 
phenol
46.5% (hy volume) 
46,5% (by volume) 
4 .65% (by volume)
2 .325% (by volume)
The dehydrated cell pellets were embedded in Araldite/ 
in gelatin at 60°G for 20 hrs, the gelatin material 
subsequently dissolved in hot water and the cell pellets 
sectioned by Electron Microscopy.
4 .3. Sectioning of Cell Pellets
EM grids (mesh size 125 fj,ra) with 64% transmission were 
pretreatred with uranyl acetate (0.83% w/v) in ethanol 
(50% v/v) in the dark, for 10 mins. The grids were washed 
in 6 changes of deionised water then placed in Reynold's 
lead citrate for 60 secs. The grids were washed in 
6 changes of deionised water and dried on filter paper. 
Sections (approximately 800 S in dia.) of the Araldite- 
émbedded cell pellets were placed on the pretreated grids. 
The sections were observed in a Phil ips 3OI G Electron 
Microscope which had been standardized for 4% error.
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5. COLLECTION OF MONONUCLEAR CELLS
5.1, Blood Samples (U. Schneider e_t j 1975)
Blood samples were collected from the umbilical 
cords of full-term pregnancies (HUCB), or the peripheral 
blood of human subjects of varying ages (HPB). Blood 
samples were added to heparin (20 i.u./ml). The hematocrit
of HUCB samples was monitored to 40% (v/v) by the addition 
of heparinized RPMI-I64O (20 l.u/ml). Mononuclear cells 
were prepared by Ficoll-hypaque density gradient centri­
fugation, from HUCB and HPB samples.
5.2. Preparation of Single Cell Suspensions
Mice (Balb/c) of varying ages were anaethesized with 
diethy1-ether for 20 mins. For the removal of livers or 
spleens, mice were first dipped in methanol to clean the 
skin of the animals. The skin just below the thoracic 
cavity was lifted with a pair of forceps and an incision 
made across the left side of the animal. Another incision 
was then made in a corresponding region of the peritoneal 
cavity. Spleens or livers were carefully removed from the 
abdominal cavity, and placed in CM (6.0 mis). The bulk of 
the organ was gripped with clean forceps and the cells 
gently teased out of their cavities. Single cell suspensions 
were obtained by passing the suspensions thrice through 
each of 4 hypodermic needles, fitted with syringes (10 ml 
capacity).
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Hypodermic Needles
lOg X ij"  1
21g X li"  2
23g X 1"  3
2 5g X 5/8"  4
The needles were used in chronological order as 
indicated. The suspensions were left at room temperature 
for 1 min, to allow any small pieces of tissue to settle 
from the cell suspensions. Mononuclear cells were 
collected hy Ficoil-hypaque density gradient centrifugation,
5,3. Ficoll-hypaque Density Gradient Centrifugation 
(A. Boyum, 1968)
Equal volumes of samples were carefully layered over 
Ficoll-hypaque solution and the gradients centrifuged at 
350 xg for 30 mins.
Ficoll-hypaque Solution
Ficoll 400 (9% w/v) 70.59% (v/v)
Sodium hypaque (33.9% w/v) 29.41% (v/v)
density, 1.078 gm/ml
The solution was sterilized hy
Millipore filtration (0.45 ^m in dia. pore size)
The opalescent band of mononuclear cells between the 
medium and the Ficoll-hypaque solution was removed and the 
cells collected by centrifugation, washed in three 
separate changes of RPMI-I64O with antibiotics and in one
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change of CM, The density of the mononuclear cell sus­
pension was determined with white cell counting fluid, 
and the %age viability determined by the Trypan blue 
exclusion test.
Under these conditions, >90% viable, mononuclear cells 
were obtained from the samples under test. Fig. 1. 
exemplifies the morphology of the cells, which were 
obtained from human blood samples.
f ,r~ '
5.3.1. Determination of Cell Density
Equal volumes of white cell counting fluid and cell 
suspensions were mixed and left at room temperature for 
10 mins.
White Cell Counting Fluid 
Gentian violet (0.1% w/v) in glacial 
acetic acid (2%).
The unlysed cells were counted in a Neubauer 
hemocytometer counting chamber.
6. ESTABLISHMENT OF EBV-TRANSFORMED CELLS
6.1. Infection of Mononuclear- Cells (adapted from
T. Katsuki , 1975)
All steps were carried out under sterile conditions. 
Mononuclear cells were obtained from human umbilical cord 
blood samples by Ficoll-hypaque density gradient 
centrifugation. After washing the cells in CM, the
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Fig. 1. Human mononuclear cells,
prepared from human umbilical 
cord blood, by Ficoll-hypaque 
density gradient centrifugation 
and stained by Giemsa's staining 
technique. (Magnification X 40)
/f  'il-,--
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viability of the cell suspensions were determined by the 
Trypan blue exclusion test and the densities brought to 
2.4 X 10^ cells/ml with freshly prepared CM.
EBV B958 or EBV QIMR-WIL was diluted in CM and equal 
volumes of virus and cell suspensions were mixed. Equal 
volumes of cell suspensions (without added virus) and CM, 
were also mixed. The suspensions were incubated at 37°C 
for 90 mins, shaking the culture flasks every 30 mins to 
facilitate adsorption and penetration of the cells. The 
cells were collected by centrifugation, suspended in CM to 
their original density and aliquots (1.0 ml) placed in 
screw-capped culture tubes (10.0 ml capacity). The tubes 
were incubated at 37°C and observed for the appearance of 
the transformed state.
6.2, Determination of the Transformed State ;
Establishment
Every 2 days after infection, each tube was examined 
for the evidence of the transformed state. This was done 
by placing the tube on the inside of a small (50 mm) petri 
dish which had been placed on the stage of a Leitz inverted 
microscope. The area of the tube which contained the cells 
was then gradually brought within the field of vision.
Fig. 2 illustrates the technique.
The initiation of the transformed state was character­
ized by the appearance of EBV-transformed foci of cells at 
the bottom of the tubes, which was eventually coupled with 
acidity of the medium.
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F ig . 2 Observation of EBV-infected cells by Leitz 
Inverted Microscopy
Cells in CM
Culture
Tube
Field of vision 
Petri dish
Microscope 
stage
Inverted
lens
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Approximately 2 weeks after the transformed state had
been established, cell suspensions were transferred to
2 2tissue culture flasks (25 cm or 75 cm ). Cell suspensions 
were also maintained as duplicate cultures in tissue culture 
tubes. I found that it was adequate to replace 3 parts of 
the cell suspensions in the tubes, by freshly prepared CM 
every 7 days. On the other hand, 3 parts of the cell 
suspensions in the tissue culture flasks were replaced by 
CM every 3 or 4 days, for the efficient maintenance of 
cultures. After 3-4 months in culture (relative to the 
time of establishment of the transformed state), the EBV- 
transf ormed cells (lymphoblastoid cell lines) were considered 
fully established. Under these conditions, some infected 
cells failed to survive the continual passages,
EBV B958 or EBV QIMR-WIL transformed cells grew as 
clumps of cells in suspension (Fig, 3). The size of the
clumps varied from small to large and was independent of the
viral strain. Fig. 4. illustrates the uninfected, 
untransformed mononuclear cells in suspension, which had 
been obtained from HUCB.
7. MAINTENANCE OF EBV-INFECTED CELL LINES
7.1. Cultural Conditions
All cell lines were maintained at 37^0 in an atmosphere 
of 5% COg, and 95% relative humidity, when in culture.
62
Fig.3. EBV-transformed mononuclear cells 
in suspension.
(Magnification XIO)
Fig.4. Uninfected, untransformed human 
mononuclear cells in suspension. 
(Magnification XlO).
• •. • -i
o O 0
y  * '
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7.2, Maintenance of Cell Stocks
Stocks of established lymphoblastoid cells were 
stored in liquid nitrogen. This was done by determining 
the viability of each LCL from 2-4 day-old cultures by 
Trypan blue exclusion test. Cultures which were 80-90% 
viable were stored in 1-2 mis freezing medium (3-5 x 10^ 
cells/ml).
Freezing Medium .
Inactivated FCS 20% (by volume)
RPMI-I64O 70% (by volume)
glycerol 10% (by volume)
The cell suspensions were stored at -70°C for 24 hrs, 
and then transferred to liquid nitrogen.
7 .3 . Rescue of Cell Stocks
Stocks of cell suspensions were brought from liquid 
nitrogen at room temperature and resuspended into equal 
volumes of preincubated (37°C) CM with 20% FCS. One half 
of the culture medium was replaced by CM with 20% FCS every 
2-3 days, until the metabolic processes of the cells had 
been restored.
8. CONTAMINATION CHECKS
8.1. Pleuropneumonia-like Organisms (PPOs)
8.1.1. Monolayer Cultures
Cells were grown on coverslips at 37°C for 3 days.
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All other steps were carried out at room temperature.
The cells were left in sodium citrate solution (0.64% 
w/v, in distilled water) for 10 mins. The cells were washed 
in two separate changes of Carnoys solution for 15 mins each 
wash.
Carnoys Solution 
Glacial acetic acid 25% (v/v)
Absolute alcohol 75% (v/v)
Orcein staining solution was added to the cells.
The cells were left for 20 mins and' then washed in three 
changes of distilled water.
Orcein Staining Solution 
Orcein stain 2% (by volume)
Glacial acetic acid 60% (by volume)
Distilled water 40% (by volume)
The cells were mounted in euperol mounting medium on
glass slides and observed with a Leitz Ordinary Light 
Microscope (XlOO lens) for the appearance or absence of 
densely stained PPOs in the smears.
8.1.2. Suspension Cultures (Gibco-bio-Cult, Europe Ltd.)
Mycoplasma broths (LMV) were inoculated with 75 mis 
cell suspension and incubated at 37*^C.
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LMV Broths
m /1
Gibco Mycoplasma broth base 21.00
Dextrose 10.00
Gibco yeast extract 25.00
Arginine HCl 10.00
Thallous acetate 0.50
Penicillin "G" 0.12
Phenol Red 0.02
Medium 199 Nucleotides (XlOO) (1.00%)
pH 7.35 - 7.45, Osmolarity 270-500
Gibco Mycoplasma Broth Base
M/1
Beef heart infusion .2.00
Peptone 220 (yeast 10.00
caesin polypeptone)
Beef extract 3.00
Sodium chloride 5.00
After 3, 10 and 17 days, Mycoplasma agar was inoculated 
with the broth cultures, by indentation of the surfaces of 
the agar. The cultures were incubated at 37°C in anaerobic 
conditions with an atmosphere of 5% 00^/95% nitrogen.
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Mycoplasma Agar
Gibco Mycoplasma base agar 34 g/l)
Gibco gamma globulin-free 20% (by volume)
horse serum
Yeast extract (25%) 0,4% (by volume)
Penicillin "G" (10 i.u./ml) 0.2% (by volume)
Thallium acetate (5%) 1.0% (by volume)
*Gibco Mycoplasma agar base was sterilized by autoclave 
(15 Ibs/sq in for 20 mins, at 121^0). The solution was 
then cooled to 48^0, added to the other components of the 
medium and the plates poured.
Mycoplasma agar plates were examined by ordinary 
light microscopy at 7 and 21 days after incubation, for the 
presence (typical ”fried-egg" appearance of colonies) or 
absence of Mycoplasma.
8.2. Bacterial
Blood agar plates were prepared according to the 
following formulation : -
Bacterial Agar/lO plates 
50 ml Blood agar."Difco Bacto"
5 ml Horse blood.-
Concentrated cell suspensions were spread on the blood 
agar plates and the plates incubated at 37^C in a humid 
chamber. If positive, colonies developed 2-5 days.
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9. IMMUNOFLUORESCENCE OF ANTIGEN-ANTIBDDY POSITIVE
CELLS
9.1. General
All microscope glass slides (76 x 26 mm) and glass 
coverslips (13 mm in dia.) were cleaned in methanol before 
use. The smears were never allowed to dry throughout the 
experimental procedures.
Viable cells were used for the detection of sig cells. 
Fixed cells were used for the detection of intracellular 
fluorescence-positive cells.
Suitable smears (see Table 2) were included in each 
test as controls for the experiments.
The mounting medium which was used throughout consisted 
of glycerol/PBS (50% v/v).
All smears were observed by u.v. illumination with a 
Leitz Ortholux u.v. microscope. At least 500 cells were 
counted on each smear to determine the %age IF**" cells.
Fixed smears were not stored for longer than 48 hrs before 
observation. Unfixed smears were observed within 5 hrs 
of preparation.
9.2. Evan's Blue Counterstaining
All steps were carried out at room temperature. The 
smears were washed in three changes of PBS-A and in one 
change of distilled water. Evan's blue staining solution 
(0.005% w/v) was added, and the smears left for 10 mins.
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Table 2 . Characteristics of Cell Lines (Controls)
Designation IF Method *IF Reactivity Reference
Ra j 1 ACIF EBNA^ B. Reedman ejb a_l, , 1973
(EA/VCA)" B. Hampar _et a_l. , 1974
BJAB ACIF EBNA“ B. Reedman ejt aj^ . , 1973
PyHR-1 DR IF (EA/VCA) G . Kleins' personal
communication.
MPC-315 IND IF sIgA (X^)* Laboratory clones
MPC-11 IND IF sIgG (k)+ I! It
Daudi DIR IF s/c IgM T. Kishimoto e_t a l . ,
1978;
(p/k)* E. Klein et. al.. , 1968
RPMI-1788 DIR IF s/c IgM T. Kishimoto ejb al..
1978
Bec-11 DIR IF s/c IgG Laboratory determined
(y/k)+
Abbreviations : .ACIF = Anti-complementary immnnofluor•
escence
IF = Immunofluorescence, 
c , 8 = cytoplasmic, surface.
* +, - = Positive, Negative 
DR, IND = Direct, Indirect.
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Evan's Blue Staining Solution
Evan's blue (dry powder) was dissolved in 
distilled water and stored as a stock, at 
room temperature as a 0.01% (w/v) solution.
The smears were washed in distilled water, in three 
successive changes of PBS, mounted, and observed by u.v. 
illumination.
9,3. Direct Immunofluorescence
9.3.1. Detection of Surface Immunoglobulins (j. Nadkarni
et a l ., 1969)
Cells were washed in two changes of PBS-A, collected 
by centrifugation and resuspended in PBS-A (2 x 10^ cells/ml) 
Cells (2 X 10 /lOO n^ l) were added to equal volumes of FITC- 
conjugated RAH antisera (Behring), which had been raised 
against IgM (^), IgG (y) heavy, Ig (k), Ig (x) light chains, 
and diluted 1 in 10 in PBS-A. The suspensions were mixed 
and incubated at 37^0 for 30 mins. Cells were collected 
by centrifugation, washed in 2 successive changes of PBS-A 
and suspended in mounting medium (20 jLtl/2 x 10 cells). 
Aliquots (10 jttl) were placed on microscope glass slides, 
coverslips added and the smears immediately observed by 
u.v. illumination for the fluorescence of Ig molecules 
on the surfaces of cells.
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9.3.2. Detection of Cytoplasmic Immunoglobulins 
( Y . Hinuma _et a_l. , 1967)
Smears were prepared from 2 day-old cultures of LCDs 
by cytocentrifugation and fixed in acetone at room 
temperature for 10 mins. The smears were washed in PBS-A. 
100 ^1 FITC-conjugated RAH antisera (Behring) which had 
been raised against IgM (^), IgG (y) heavy; and Ig (k),
Ig (À) light chain types, and diluted 1 in 10 in PBS-A 
were added. The smears were incubated at 37°G for 30 mins, 
counterstained in Evan's blue staining solution, mounted 
and observed by u.v. illumination for the fluorescence of 
Ig molecules in the cytoplasms of cig* cells,
9.3.3. Detection of Early and Virus Capsid Antigens 
(G. Klein's personal communication).
Smears were prepared from 2 day-old cultures of LCLs 
by cytocentrifugation and fixed in acetone at -20^0 for 
10 mins. The smears were washed in PBS-A, FITC-conjugated 
VGA* (F^-Katana.) or (EA/VGA)^ (F^-Esther) antisera which 
were diluted 1 in 40 in PBS-A were added (lOO /il).
The smears were left at room temperature for 1 hr, 
counterstained in Evan’s blue staining solution, mounted 
and observed by u.v. illumination for the intracellular 
fluorescence of VGA and/or EA positive cells.
9.4. Anticomplementary Immunofluorescence (B. Reedman
_et , 1973)
Smears were prepared by cytocentrifugation, fixed at
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~20°C for 15 mins and washed in PBS-A.
ACIF Fixative 
Acetone 2 parts
Methanol 1 part
100 /il FBNA^ (Walter Owino) or EBNA (Ingela) human antiserum
(a/s) which had been diluted 1 in 10 in PBS-A, was added.
The smears were incubated at 37°C for 15-mins, washed in
three separate changes of PBS-A and 100 /il complement (O’,
Eva Klein) which had been diluted 1 in 10 in PBS-A, added.
The smears were incubated at 37^0 for 15 mins and washed in
three separate changes of PBS-A. 100 jttl FITC-con jugated
r,,A- .
component of complement (FITC-'p^^, Dr. George Klein), 
which had been diluted 1 in 20 in PBS-A, was added. The 
smears were left at room temperature for 30 mins, counter­
stained in Evan’s blue solution, mounted and observed by 
u.v, illumination for nuclear fluorescence of EBNA.
BJAB, Raji, HUCLs
The following tests controlled the ACIF test
EBNA* or EBNA" a/s; C ’; FITC^P
1 c
EBNA* or EBNA" a/s; C ’; PBS-A ^
+ 7^ ' '
EBNA or EBNA" a/s; PBS-A; FITC^P^
BJAB, Raji, HUCLs 
BJAB, Raji, HUCLs 
BJAB, Raji, HUCLs
fi-f 1.
PBS-A ; C ’ ; FlTc/p_' / Ic
Nuclear staining for EBNA was never observed when BJAB
“f*
or HUCLs were tested against EBNA antiserum. On the other 
hand, Raji always displayed nuclear fluorescence for EBNA 
when Walter Owino, but not when Ingela antiserum was used in 
the ACIF test.
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9.5, Indirect Immunofluorescence (D.M. Weir, 1978)
Mononuclear cell suspensions were prepared from single 
cell suspensions by Ficoll-hypaque density gradient 
centrifugation. The cells were washed in two successive 
changes of PBS-A. The densities of the mononuclear cell 
suspensions were determined with white cell counting fluid, 
and the ^age viability of each suspension determined by the 
Trypan blue exclusion test. Cells were collected by 
centrifugation and resuspended in PBS-A (2 x 10^ cells/ml).
100 /xl, containing 0.6 mg Rabbit anti-mouse (RAM) 
antiserum (Table 3) which had been raised against Ig (k) or 
Ig ( ^ 2 ^ iri PBS-A, was added to 2 x 10 cells (in 100 /il
PBS-A), The cell suspensions were mixed and incubated at.
37°C for 30 mins - in some cases, cells were incubated at 
4^C. Cells were collected by centrifugation at 200 xg 
for 10 mins, washed in two changes, and resuspended in,
100 /il PBS-A. 100 /il FITC-con jugate d GAR IgG, containing 
0.7 mg protein (FITC-GAR IgG) was added, the cell suspensions 
mixed, and incubated at 37°C (or 4^G). Cells were collected 
by centrifugation, washed in two changes of PBS-A and 
collected by centrifugation. Mounting medium Was added 
(20 /il/2 X 10 cells), aliquots .(lO /il) placed on microscope
glass slides, coverslips added, and the smears immediately
observed by u.v. illumination for the fluorescence of surface 
immunoglobulin positive cells.
The following tests controlled the Indirect IF : -
MPC-315, MPC-11 
MPC-315, MPC-11 
MPC-315, MPC-11 
MPC-315, MPC-11 
MPC-315, MPC-11
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RAM I g (k) or Ig 
PBS-A
RAM Ig (k) or Ig ( )
NRS (1:10 in PBS-A) 
NRS (1:10 in PBS-A)
FITC-GAR IgG 
FITC-GAR IgG 
PBS-A
FITC-GAR IgG 
PBS-A
Abbreviation: NRS = Normal Rabbit Serum.
There was no statistically significant difference 
observed between the %age sig* cells, whether the experiment 
was conducted at 37°C or 4^C. sig* cells were never observed 
when NRS and FITC-GAR IgG were added to MPC-315 or MPC-11. 
sig cells were never observed when MPC-315 were tested 
against RAM Ig (k) or when MPC-11 were tested against RAM 
Ig (Xg) with FITC-GAR IgG. sIg* cells (3 0-40%) were observed 
when MPC-315 were tested against RAM Ig (Xg) and when MPC-11 
were tested against RAM Ig (k) with FITC-GAR IgG. RAM Ig 
(Xg) was specific for X* while RAM Ig (k) was specific for 
k* cells.
10. Acquisition of Laboratory Prepared Antibodies
Table 3 displays a summary of the techniques, and antigens 
which were employed for the preparation of antibodies.
10.1. Boric Acid Precipitation of Euglobulins
Serum samples containing the myeloma proteins were 
centrifuged at 10,000 xg to remove insoluble material.
The centrifuged samples were then added in a dropwise manner, 
while mixing, to solutions of 2% (w/v) boric acid (twenty
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Table 3. Acquisition and Purification of
Antibody Preparations
Antibody From Against Selected On
Antisera Antigen Immunoadsorbent
RAM I gA ( Xg ) BO/Ac MPC-315 IgA (Ag)
DNP-Lys(SR) (IgA (Xg))
G-lOO
RAM IgGg^(k) (NH^)g80^ MPC-11 IgGg^ (Ic)
A-50 (IgGg^(k))
GAR IgG G-200 Rb IgG Nordic IgG
RAH IgM Bo/Ac IgM k(7A) IgM (X)
G-200
Abbreviations : G-200, A-50, G-lOO = Ion Exchangers
(NH^)gSO , = Ammonium 
4
sulphate
Bo/Ac ■= Boric Acid
DNP-Lys(SR) = DNP-lysine (Sepharose)
Note : All antibody preparations were determined to be
pure by immunoelectrophoretic techniques. There
wa s no cross-reactivity observed -between RAM IgA
( and RAM IgG 2b(k).
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times the volume of the serum samples). After standing 
at room temperature for 2 hrs, the precipitates were 
collected by centrifugation at 10,000 xg for 30 mins.
The precipitates were then dissolved and dialysed against 
G-200, or DNP-lys (Sepharose) buffers.
10.2. Ammonium Sulphate Precipitation
The serum sample containing the Immunoglobulin protein 
was centrifuged at 10,000 xg for 15 mins to remove insoluble 
material. The serum sample was then diluted with equal 
volume of PBS-A, and saturated ammonium sulphate (53.6% w/v) 
added in a dropwise manner, while mixing, until 40% saturat­
ion was attained. After leaving at room temperature for 2hrs, 
the precipitate was collected by centrifugation at 10,000 xg 
for 30 mins. The precipitate was washed once with 40% satur­
ated ammonium sulphate and then dissolved in a suitable 
volume of PBS-A, The solution of antiserum was then 
dialysed extensively (48 hrs) against A-50 column buffer.
10.3 . Sephadex G-200 Column Chromatography
A column (2.5 cm in dia. x 100 cm in length in a bed 
volume of 500 ml) was packed with Sephadex G-200 which had 
been equilibrated in column buffer and degassed.
G-200 Column Buffer 
0.1 M Tris-HGl
0.2 M NaCl
pH 8.0
77
The dialysed sample of antiserum was centrifuged at
30,000 xg for 30 mins to remove insoluble material and the 
sample carefully added to the sample bed. This was done by 
removing any excess column buffer which was at the top of 
the column bed and the sample slowly added to the column bed. 
The column was then connected by an air-tight system to a 
reservoir of column buffer. The reservoir of column buffer 
was at a height above the level of the column head, to 
enable the efficient passage of the reservoir buffer, and 
maintenance of the flow rate. The flow rate (10-15 mls/hr) 
was achieved by the adjustment of the hydrostatic pressure 
head. Fractions (2-5 mis) were collected, the absorbance 
(Aggo) determined, the peak fractions containing the antigen 
pooled, and concentrated by Amicon filtration.
10.4 . ' Sephadex A-50 Column Chromatography
A column (2.5 cm in dia. x 100 cm in length in a bed 
volume of 500 ml) was packed with Sephadex A-50 which had 
been equilibrated with column buffer and degassed.
A-50 Column Buffer 
1 M KHgPO^
1 M KgHPO^
pH 8.0
A 0.01 M solution was prepared for use.
The dialysed sample of antiserum was centrifuged and 
applied to the column bed as detailed in 10.3. The protein 
fractions were eluted with a gradient of column buffer,
0,01 M - 0.30 M. The absorbance (Agg^) of the fractions
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were determined, the peak fractions pooled and concentrated 
hy Amicon filtration.
10.5. DNP-lysine (Sepharose) Column Chromatography
A column (1.0 cm in dia. x 20 cm in length, in a bed 
volume of 1 ml/ml sample) was packed with DNP-lysine (Seph­
arose), DNP-Lys(SR), which had been washed with 5 volumes 
acetic acid (25%) and 10 volumes column buffer.
DNP-Lys(SR) Column Buffer 
0.2 M Tric-HCl, pH 8.0
The dialysed serum sample was filtered by Millipore 
filtration and equal volume of column buffer added. The 
sample was added to the DNP-lys(SR) column. Two separate 
volumes of column buffer/dithiothreitol (DTT) was added, the 
flow stopped, and the column left at room temperature for 
30 mins after each addition. The column was washed with 
two changes of 10 mM iodoacetic acid (lAA). 0.2 volume 
of column buffer/O.Ol M DNP-aminocaprioic acid (APA) was 
added and a reservoir of column buffer applied as detailed 
in 10.3. Fractions were collected and the absorbance 
determined as follows :
AggQ(DNP-APA) : -^280“*^ “ ^ ^^^"^360^ " "^280
The peak fractions were pooled, dialysed against 
column buffer, partially reduced, and alkylated.
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10.5.1. Partial Reduction and Alkylation
50 JuM DTT, and 20 pi phenol red was added to the 
dialysed samples and the mixture incubated at 37°C for 
30 mins. 150 mM lAA was added, while stirring, 0.1 volume 
1 N NaOH (pH 8-8 .4) added and the mixture left at room 
temperature for 15 mins. The samples were then dialysed 
against G-lOO column buffer for 48 hrs.
10.6, Sephadex G-IOQ Column Chromatography.
A column (1.0 cm in dia. x 20 cm in length in a bed 
volume of 1 ml/ml sample) was packed with Sephadex G-lOO 
which had been equilibrated with column buffer and degassed.
G-IQO Column Buffer 
6 M Urea-Formate, pH 8.0
The dialysed samples were centrifuged and applied to 
the column beds as detailed in 10.3. Fractions were 
collected, the absorbance (A^g^) determined, the peak 
fractions pooled, and concentrated by Amicon filtration.
10.7. Acquisition of Rabit Antisera
An equal volume of immunoglobulin preparation (0,5 -
1.0 ml) was mixed with complete Freund’s adjuvant. After 
émulsification of the mixture by sonication, it was adminis­
tered to the rabbits in the form of two primary injections, 
intravenously (0.2 - 1.0 mg per injection). Within the 
fourth week after the second primary injection, booster 
injections were administered at various sites of the animal.
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subcutaneously (0.2 mg protein per injection). Within the 
sixth week after the final booster injection, the animals 
were bled from the ear veins. The rabbits were repeatedly 
bled at 1-2 week intervals, 20-50 mis blood being taken at 
each bleeding. The blood samples were incubated at 37^0
for 30 mins and then at for 20 hrs to enable clotting
to take place. The serum samples were filtered and stored
at -20^0 until ready for use.
10.8. Sepharose Affinity Chromatography
Sepharose 4-B was washed extensively in distilled water 
and then activated in a fume cupboard with cyanogen bromide 
(CNBr),using; 100 mg GNBr/ml sepharose, but 2 5% (v/v) 
sepharose. The pH of the sepharose was then monitored with 
5 N sodium hydroxide to 11,0 - 11.5, while mixing. The 
sepharose was then immediately washed in, and resuspended in, 
ice-cold 0.1 M NaHGOg, using five times the volume of the 
sepharose.
The sample to be coupled (1-10 mg Ig/ml sepharose) was 
then added and the reaction allowed to continue at for
16 hr, while mixing. Eluates were collected and the 
sepharose washed with 0,1 M NaHCO^. The absorbance (A^g^) 
of the eluates was determined and the total uncoupled 
immunoglobulin determined. The amount of coupled Ig was 
calculated according to the following formula :- 
Coupled Ig = (Total Ig) - (Uncoupled Ig).
The sepharose was then reacted at 4°C for 16 hr with
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a molar equivalent (relative to the CNBr) of glycine to 
quench any remaining active sites, washed in, and resuspended 
in, PBS-A containing 0.05% sodium aside-as the preservative. 
The sepharose was stored at 4^C .
10.9. Purification of Antibody Preparations
The sepharose-bound Ig was loaded into a small dis­
posable syringe which served as a column. The column was 
prepared by cutting a Millipore glass fibre filter to the 
appropriate size and placing it at the bottom of the syringe. 
The antiserum to be purified was applied to, and allowed to 
pass through the column, at room temperature. Fractions 
were collected, the column washed once with PBS-A (v/v anti­
serum) , and twice with at least five times the volume of 
antiserum, with PBS-A. The absorbance of the fractions was 
noted (Agg^) and the washings suspended when Agg^ began to 
decrease to near zero. The bound antibodies were eluted 
with one of the following solutions
0.1 M Acetic Acid
1.0 M Propionic Acid
0.1 M Glycine HCl, pH 2.8.
The eluates were collected,' the elution buffer
neutralized with a suitable volume of 1 M Tris, and the
absorbance (Aggg) noted until it began to decrease
significantly to near zero. The peak fractions were pooled,
dialysed against PBS-A, concentrated, and stored in aliquots 
at -20°C.
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11. FITC-Conjugatlon of GAR IgG (D.M. Weir, 1978)
GAR IgG was centrifuged at 30,000 xg for 30 mins to 
remove insoluble material and chilled. 0.5 M sodium 
bicarbonate buffer (10% v/v) was added.
Sodium Bicarbonate Buffer 
NaHCOg 3.7% w/v
NCgCOg 0.6% w/v
pH 9.0
Fluorescein isothiocyanate (FITC) was added (50 /xg/mg 
Ig protein), while mixing, and the reaction allowed to 
proceed for a further 6 hrs at room temperature. The 
conjugated antibody preparation was then dialysed against 
PBS-A for 48 hrs, centrifuged at 30,000 xg for 1 hr to 
remove insoluble material and stored in aliquots at -20^0.
12. ANALYSIS OF LABELLED IMMUNOGLOBULIN PROTEINS
12.1. Biosynthetic Labelling of Lymphoblastoid Cells
(Adapted from an unpublished manuscript of Dr. T. Mossman) 
Cells from 2 day-old cultures of cell lines which had 
been maintained in culture for 18-20 months after the 
establishment of the transformed state were washed in two 
changes, and suspended in, labelling medium.
Labelling Medium 
RPMI-I64O without L-leucine 
or L-methionine
Lyophilized, labelled ^H-leucine, or ^^S-methionine
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(100 /xCi) was dissolved in labelling medium (100 /xl)' and 
added to 4 % 10^ cells in 100 /xl labelling medium. The 
suspensions were incubated at 37°C after mixing, and mixed 
every 15 mins after incubation, to disrupt cell clumps,
12.2. Collection of Intracellular Proteins
All steps were carried out in an ice bath. Samples 
were removed from biosynthetically labelled cell suspensions 
after 30 mins incubation, and added to ice-cold CM (20 parts 
to 1 part cell suspension). The cells were collected by 
centrifugation and the pellets completely disrupted. The 
cells were then resuspended in lysis buffer-1 (4& times the 
original volume of the cell suspension).
Lysis Buffer-1
TKM (XIO) 8 parts
Triton X-100 (10% v/v) 1 part
TKM (XIO)
Tris-HCl, pH 8.2 100 mM
potassium chloride 100 mM
Magnesium chloride 5 mM
The cell suspensions were left for 15 mins, to
facilitate cellular lysis and the cytoplasmic lysates
collected by centrifugation at 400 xg for 15 mins. Lysis
buffer II was added (1 part to 9 parts cytoplasmic lysate) 
and the cellular debris removed by centrifugation at 30,000 
xg for 1 hr.
Lysis Buffer II 
Sodium deoxycholate . 10% (w/v)
SDS 5% (w/v)
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12.3. Effect of Cell Density on the Level of 
Incorporation
Various cell densities (1-7 x 10^) from 2 day-old 
cultures of Q,WELB78 which were >90% viable were labelled
3
biosynthetically (12.1., Methods) with H-leucine (100 ^Ci) 
Intracellular proteins were collected (12.2., Methods), 
immune precipitates obtained (12.6., Methods) and the %age 
incorporation determined for each cell density which was 
used in the test, by Liquid Scintillation Spectrometry 
(12.5., Methods). The data was represented graphically as 
illustrated in Fig. 6.
The %age incorporation was found to increase with the 
number of cells, up to and including a cell density of 
5 X 10^ cells. Similar results were obtained with other 
cell lines (B9ELB78 and QWIM77) which were substituted 
for QWELB78 in this test. 4 x 10^ cells were used through­
out the analysis of Ig proteins of 18-20 month-old cultures 
because this density from cultures which were >90% viable 
was most easily attained from 2 day-old cultures.
12.4. Collection of Secreted Proteins
(T. Mossman, unpublished Manuscript; J. Andersson e_t a l , , 
1974)
3 5 3
After 2 ( S-methionine label) or 4 ( H-leucine label)
hrs, samples (100 /il) were collected from biosynthetically
labelled cells, and chilled. Ice-cold RPMI-I64O (350 /xl)
was added and supernatant solutions were collected by
centrifugation at 4OO xg for 15 mins.
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3D-TKM buffer was added (one part to nine parts supernatant)
3D-TKM Buffer
Sodium deoxycholate (10% w/v) 1 part
Triton X-lOO (10% v/v) 1 part
SDS (5% w/v) 1 part
TKM (XIO) 1 part
. Distilled water 6 parts
The cell-free extracts were centrifuged at 30,000 xg 
for 1 hr to further purify the extract.
12.5. Determination of Antibody Equivalence
Intraeellularly labelled proteins were collected from
biosynthetically labelled QWELB78 cells. Varying amounts
(5-100 /xg) of RAH IgM was added to constant volumes (50 /Xl)
of samples in each of 4 sets of tubes. The samples were
mixed and incubated at 37^0 for 30 mins. Various quantities
(10, 15, 25 or 50 /xg) of GAR IgG were added to the 4 sets
of tubes in turn, the suspensions mixed and incubated at
37°C for 30 mins. The samples were then left at room
temperature for 30 mins and the reaction of immune pre-
o
cipitation prolonged at 4 C for 20 hrs. Precipitates were 
collected by centrifugation at 8,000 xg for 2 mins, washed 
in two changes, and dissolved in 50 /xl 3D-TKM. The amount 
of radioactivity in each sample was determined by Liquid 
Scintillation Spectrometry.
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12.6. Liquid Scintillation Spectrometry
Aliquots (10 pi) of samples were added to 5 pi CM,
1.0 ml 10^ (w/v) TCA was added and the precipitates 
collected by centrifugation at 8,000 xg for 2 mins.
The precipitates were dissolved in 100 pi Hyamine 10-X 
hydroxide and the mixture added to scintillation counting 
fluid (2,0 ml) as a 5^ solution.
Hyamine 10-X Hydroxide 
Scintillation grade with about 
10^ (w/v) in methanol
Scintillation Counting Fluid 
PPO (0.4%) in toluene
The amount of radioactivity in each sample was 
determined in a Beckman LS 333 Scintillation Counter, with 
85 and 90 % efficiency for p (^H-) and y (^^S-) radiation. 
The %age incorporation of labelled amino acids into 
immunoglobulin proteins was determined by the following 
formula : -
%age Incorporation = CPM of Sample ^ pQQ
3.7 X 10"^
The maximum level of incorporation was achieved with 15 pg 
RAH IgM and 15 pg GAR IgG (Fig. 5). The maximal level of 
incorporation was found to be similar when RAH antisera 
which had been raised against y , k or \ (Miles) antibodies 
were titrated against GAR IgG. The antibody equivalence 
was accepted to be achieved with 15 pg RAH antiserum and 
15 pg GAR IgG.
12.7, Indirect Inununoprecipitation of Ig Proteins
RAH antisera which had been raised against p, y , k or 
X antibodies (15 pg in 15 pi PBS-A) were added to aliquots 
(50 pi) of labelled intracellular or secreted protein 
samples. The samples were mixed and incubated at 37°C for 
30 mins. 15 pg GAR IgG in 15 pi PBS-A was added, the 
samples mixed and incubated at 37^0 for 30 mins. The 
samples were then left at room temperature for 30 mins to 
promote the development of immune precipitates, and the 
reaction prolonged at 4°0 for 20 hrs. Precipitates were 
collected by centrifugation at 8,000 xg for 2 rains, and 
washed in two changes of 3D-TKM. Precipitates were 
collected by centrifugation at 8,000 xg for 2 mins and 
dissolved in 50 pi sample buffer for discontinuous 8DS- 
polyacrylamide gel-electrophoresis. The radioactivity in 
10 pi samples was determined by Liquid Scintillation Spec­
trometry and the exposure times for fluorographs determined
13. DISCONTINUOUS SDS-POLYACRYLAMIDE GEL-ELECTROPHORESIS
(U, Laemmli, 1970).
13.1, Stock Solutions
The following stock solutions were prepared as indicated 
and stored for not more than 1 month : -
Solution A
Acrylamide 45% (w/v)
bis-Acrylamide 1.2% (w/v)
Solution B, pH 8.8
Trizma Base 18.0% (w/v)
TEMED 0.13% (w/v)
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Solution G , pH 6.8
Trizma Base 7.0 % (w/v)
Solution D
SDS 12% (w/v)
Glycine Reservoir Buffer, pH 8.8 
Trizma Base 0.025 M
Glycine 0.192 M
SDS 0.10% (w/v)
Solutions A, B and C were stored at 4^0.
Solutions D and Reservoir buffer were stored at 
room temperature.
Sample Buffer
Solution C 1 part
Glycerol 1 part
SDS (10% w/v) 2 parts
DTT 100 mM
Distilled water containing
bromophenol blue (0.01 mg/ml) 6 parts
The solution was stored at -20°C.
13.2. Preparation of Separating Gel
Two glass plates were aligned, but separated by plastic 
tubing (relative to the size of the gel), and secured in an 
upright position on a perspex stand. Separating gel 
(21 X 26 X 0.5 cm) containing 12.0 % acrylamide was 
prepared according to the following formulation ; -
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Separating Gel 
33.3 mis Solution A
30.0 mis Solution B
1.0 ml Solution C
The mixture was made up to 120 mis with distilled 
water, degassed, and ammonium persulphate (1 mg/ml) added 
to chemically induce the formation of free radicals. The 
mixture was immediately poured between the glass plates and 
left at room temperature for 1 hr to promote cross-linking 
and the subsequent polymerization of the acrylamide,
13.3 . Preparation of Stacking Gel
The stacking gel which formed the discontinuous layer, 
contained 5% acrylamide and was prepared according to the 
following formulation
Stacking Gel
2.64 mis Solution A
2.40 mis Solution D
0.20 mis Solution C
18.67 mis Distille d
24 i^ l TEMED
A 26 place sample well template (made from Teflon) was 
inserted between the glass plates, above the top of the 
separating gel. The stacking gel solution was degassed, 
ammonium persulphate added, the mixture immediately poured 
and then left at room temperature for 20 mins to polymerize. 
When the gel had set, the sample well template was removed 
and the sample wells flushed with distilled water to remove
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any undesirable fragment of stacking gel.
13.4. Electrophoresis of Samples
Samples (30 p,l) of immunoprecipitates which had been 
dissolved in sample buffer, were reduced by heating at lOO^C 
for 2 mins. Reservoir buffer was poured in the troughs of 
the perspex stand. The samples were then carefully loaded 
into the sample wells, underneath the Reservoir buffer.
The samples were then electrophoresed at 12 mA/gel, with 
constant current, at 4°C for 20-26 hrs.
13.5. Fluorography of Slab Gels
(Adapted from W. Bonner e_t a^. , 1974)
The protein bands were fixed in the separating gel as 
follows : -
DMSO (250 ml) 20 mins
DMSO (250 ml) 20 mins
DMSO (2 50 ml) 40 mins
The gels were incubated at 30^0 in a mixture of PPO/DMSO 
(20% w/v) for 45 mins with constant shaking, to. facilitate 
complete impregnation of the gels. The excess PPO/DMSO was 
removed and the gel rinsed in, and washed in, running tap 
water for 1 hr, at room temperature. The gels were then 
dried on Whatmann chromatographic paper (3 mm) under pressure. 
The dried gels were placed between two glass plates (25 x 30 cm). 
Kodak X-Omat H film (24 x 30 cm) was.inserted between the gel 
and the glass plate, ensuring that the film was in contact
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with the dried gel. The gels were then placed in individual
light proof vinyl film hags and left at -70°C for 21
3 5 3( S-methionine) or 42 ( H-leucine) days.
13.6. Development of Films
The films were processed at room temperature in the 
dark. Films were placed in DX-80 developer (Kodak) for 
10 mins. The protein bands were fixed in FX-40 X-Ray liquid 
fixer (Kodak) for 10 mins. The films were washed in running 
tap water for 30 mins and air-dried at room temperature.
RESULTS AND DISCUSSIONS
Chapter 1
The Transforming Efficiencies 
of EBV Strains,
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1.1. Establishment of Pairs of EBV-Transformed
Cell Lines.
1.1.1. Introduction
Mononuclear cell populations were obtained from human 
umbilical cord blood samples (Methods, 5.1.) by Ficoll- 
hypaque density gradient centrifugation (Methods, 5.3.).
Each sample of cell suspension was brought to 2.4 x 10^ 
viable cells/ml with freshly prepared CM, and divided into 
three portions. EBV B958 or EBV QIMR-WIL stocks (Methods, 3.) 
were diluted in freshly prepared CM (4 parts to 1 part virus 
suspension). Each virus suspension in turn was mixed with 
equal volumes of one of three portions of cell suspensions.
Equal volumes of the third portion of each cell suspension 
(without added virus) and CM were also mixed. The suspen­
sions were incubated at 37°C, shaking the flasks every 30 
mins, to facilitate adsorption and penetration of the cells.
Cells were collected from the infected and uninfected 
suspensions by centrifugation at 200 xg, after 90 mins 
incubation and suspended in CM to their original densities 
(1.2 X 10^ cells/ml). Aliquots (1.0 ml, x3) from each 
infected and uninfected cell suspension were placed in 
screw-capped tissue culture tubes (10 ml capacity) and the 
suspensions incubated at 37^0. The suspensions were then 
observed daily with Leitz inverted microscope (Methods, 6.2) 
for the appearance of the transformed state.
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1.1.2, Establishment of the Transformed State.
The transformed state was characterized by the 
appearance of transformed foci of cells when coupled with 
acidity of the medium. Transformed foci of cells were 
never observed among uninfected mononuclear cell 
populations. Approximately 3 days after infection and 
incubation, degeneration of the cultures began. While 
uninfected cultures continuously degenerated, the 
transformed state could be noted among pairs of EBV (B95B) 
and EBV (QIMR-WIL) infected cells.
1.1.3. Designation of Pairs of Cell Lines,
The transformed state for 16 pairs of cell lines was 
noted, A pair of cell lines was designated following the 
acquisition of 2 cell lines which had been obtained from 
one sample of mononuclear cell preparation by infection 
with EBV B958 and EBV QIMR-WIL, Each pair was designated as 
follows : - •
Virus strain B9 or QW
Maternal donor e,g, B9 or QW SD
Year of establishment B9 or QW SD 77 or 7B
Samples of transformed cultures were transferred from
tissue culture tubes to flasks (25 cm ), approximately 14 
days after the appearance of the transformed state, and 
subcultured every 3-4 days.
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1.1.4. Discussion
Among the B9 infected cultures, the time lapse between 
infection and the establishment of the transformed state 
varied between 10 and 19 days, with an average of 12.Ô - 
0,5 days; Table 1.^columns 1 and 2. QW infected 
cultures on the other hand, remained in culture for nearly 
twice as long, before the transformed state was fully 
established. The time lapse for QW infected cells varied 
between 16.7 and 33.0, with an average of 24.2 - 1,5 days; 
Table 1.1,columns 3 and 4. In most cases (Table 1.1),each 
time lapse determination was an average of 3 cultures.
When in suspension as single cells, B9 transformed cells 
were much larger than QW transformed cells. 1-2 days after 
subculture, some QW transformed cells adhered as monolayers 
to the culture flasks. However, this characteristic was not 
long lived. The "adherent” cells Just as spontaneously as 
they adhered, resuspended themselves as clumps of cells 
before the next passage.
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Table 1.1 Cell Line s and Time Lapses
B9 transformed 
Designation TL (days)
QW transformed 
Designation TL (days)
B9SD77 12.3 QWSD77 17.3
B9FL77 13.0 QWFL77 22.0
B9MM77 10.0 QWMM77 20.0
B9AW77 13.0 QWAW77 23.7
B9RK77 17.0 QWRK77 31.0
B9EL77 19.0 QWEL77 33.0
B91M77 13.0 QW1M77 30.0
B9AB77 12.3 QWAB77 29.0
B9ELB7B 10.0 QWELB78 26.0
B9E1F78 12.3 QWE1F78 16.7
B9SAM78 10.7 ■ QWSAM78 16.7
B9BEB78 12.3 QWBEB78 26.0
B9L0C78 13.0 QWL0C78 22.0
B9MAC78 15.7 ■ QWMAG78 28.0
B9E1B78 16.5 QWE1B78 27.0
B9MAC78 11.5 QWMAC78 18.3
Abbreviation : TL = Time Lapse
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1.2. Kinetics of the Transformed State.
1.2.1. Introduction
Samples were collected from HUCB (Methods, 5.1). 
Mononuclear cells were collected hy Ficoll-hypaque density 
gradient centrifugation (Methods, 5.3) and the viability and 
density of each cell suspension determined (Methods; 2.2,
5.3.1). Cell suspensions from 4 HUCB samples were 
infected with equal volumes of 4 separate suspensions of 
EBV B958 (10 ^ dilution) as described in Methods, 6,1. 
Samples (l.O ml x 60) from each of the 4 HUCB samples were
incubated at 37°G. On days ; 4, 8 and 12 after infection,
one half of the culture medium was replaced by'freshly 
prepared CM without resuspending the cells. On days ;
17, 22 and 27, the cells in the suspensions were resuspended 
in the culture medium and one half replaced by freshly 
prepared CM, Cell suspensions (1.2 x 10^ cells/ml) 
without added virus were incubated as controls.
Samples (x3) were removed at various time intervals and 
the total number of viable cells determined by the Trypan 
blue exclusion test. The percentage blastoi.d cells in 
each sample was calculated by the following formula :-
Percentage Blastoid _ No. of Blastoid Cells ^
cells No. of Viable Cells
Fig. ID illustrates the mononuclear cells which were 
regarded as being blastoid in morphology.
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Smears were prepared from each sample hy cyto- 
centrifugation (Methods, 2.1) for the determination of 
percentage (EBNA)^ cells (Methods, 9.4) for each sample.
All smears were stored at -70^C until 15 and 30 days after 
infection, when half and all the samples had been collected 
Fig. 1 represents the data collated from the 4 samples of 
HUCB which were treated to elucidate the kinetics of the 
transformed state.
1.2.2. Discussion
The total number of viable cells decreased from
1.1 X 10^/ml on day 2 to 0.9 x 10^/ml on day 6 (arrowed in 
Fig lA) after infection. This decrease in the number of 
viable cells was due to the fact that uninfected cells in 
culture began to degenerate during this period (Results,
1.1.2). The decrease in viability of the samples 
coincided with a plateau of about 24^ blastoid cells 
between 2 and 6 days. Fig. IB. Between 6 and 13 days 
after infection (arrowed in Fig. IB), the number of viable 
cells increased from 0.8 x 10^/ml to 1.0 x 10^/ml.
This event coincided with a sharp increase in the percent 
blastoid cells as the B9 transformed cells began to 
proliferate logarithmically. The percentage blastoid 
cells increased from 23.5 to 99, 13 days after -infection.
A plateau of 100% blastoid cells was observed and 
maintained in the culture from 14 days after infection 
onwards.
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These findings would suggest that, although EBV- 
transformed cells were in culture from as early as < 2 days 
(when (EBNA) cells were detectable, Fig. IC) after infection, 
a certain percentage of blastoid/B9-transformed cells has to 
be attained before the transformed state can become fully i 
established. These conditions are applicable when a virus 
dilution of 10 ^ (TD-^^/ml = 10^’^) is used with cell density 
of 1.2 X 10^/ml for the establishment of LCLs.
The appearance of the transformed state on day 2 was 
characterized by the detection of EBNA in 1.3% of the 
samples. The percent (EBNA)^ cells increased from 1,3 on 
day 2 to 19.0 on day I4, when the transformed state was fully; 
established. (EBNA)* cells increased from 19% on day I4 to 
70% on day 27 after infection. The detection of blastogenesis 
occurred before the detection of EBNA in this system. 24 hrs 
after infection, 20% of the cells was blastoid, when EBNA was 
not detectable. Once the transformed state had been fully 
established, the number of (EBNA) cells increased at a much 
faster rate (day I4 onwards) than prior to the establishment 
of the transformed state (O-I4 days).
The percent. (EBNA)* cells seemed somewhat low in this 
system. I think that this could have been due to the fact 
that the experiment was carried out in tissue culture tubes 
which have small surface areas. Overcrowding of the cells 
occurred, to limit the percentage• viability of the culture. 
However, tissue culture tubes were most suitable for this
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Fig. 1 Kinetics of the transformed state
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A : Total number viable cells 
B : %age Blastoid cells 
C : %age EBNA positive cells
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experiment as it was being conducted over a long period 
of time (30 days), thus limiting the probability of 
contamination of the cultures.
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Fig. IDo B9 transformed lymphoblastoid cells 
from HUCB ; stained by Giemsa’s staining 
technique (Methods, 2.3); photographed with 
Ektachrome 50. (Magnification x 40).
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1.3. Transforming Efficiencies of EBV B958 and
EBV QIMR-WIL.
I.3.I0 Introduction
Suspensions of EBV B958 and EBV QIMR-WIL were diluted 
ten-fold in freshly prepared CM (10 ^ - 10 ^). Mononuclear 
cells were collected from HUCB samples by Ficoll-hypaque 
density gradient centrifugation and the cell densities 
brought to 2.4 X 10^ viable cells/ml with freshly prepared 
CM. Equal volumes of cell suspensions from each of 
6 HUCB samples were mixed with each dilution of virus in 
turn. Equal volumes of cell suspensions and CM (without 
added virus) were also mixed. The suspensions were 
incubated at 37°C, shaking the flasks every 30 mins.
After 90 mins, the cells were collected by centrifugation 
at 200 xg for 10 mins. Aliquots (1.0 ml) were placed in 
tissue culture tubes (x4 for each virus dilution), and 
incubated at 37°C. The tubes were observed daily for 
evidence of the transformed state (Methods, 6.2). Half of 
the culture medium in each tube was replaced by freshly 
prepared CM every 3 days for 6 weeks or until the trans­
formed state was evident. The transformed state was never 
evident in uninfected cultures."
1.3 .2 . Calculation of Transforming Efficiencies.
The transforming efficiency (TE) for each virus strain 
was used to describe the reciprocal of the virus dilution 
which induced 50% of replicate cultures to proliferate.
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Here, 50% of replicate cultures was represented by 2 tubes 
TE was calculated from the data in Table 1.2, by the 
following formula (Reed e_t a_l. , 1938)
No. of transformed cultures 
above 50%
TE = ----------------------------------------------------------
No. of transformed cultures No, of transformed
above 50% cultures below 50%
Table 2 displays the data which was collated from the 12 
HUCB samples when infected by EBV B958 and EBV QIMR-WIL.
TE for EBV B958. and EBV QIMR-WIL were determined to be 
10^*^ and 10^*^ TD^^/ml respectively.
Table 1.2. Transforming
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Efficienc y Determination of
EBV B958 and EBV QIMR- WIL.
EBV Strain RLD NIC NUC CIN CUN FIN %IN
B958 1 24 0 70 0 ^0/70 100
2 22 2 46 2 46/48 95.8
3 18 6 24 8 24/32 75.0
_ 4 6 18 6 26 ^/32 18.8
5 0 24 0 50 0/50 0.0
QIMR-WIL 1 8 16 16 16 ^6/32 50
2 5 19 8 35 3/43 18.6
3 3 21 3 56 2/59 5.1
4 0 24 0 80 • 0/80 0.0
5 0 24 0 104 0/104. 0.0
Abbreviations ; -
RLD = Reciprocal log dilution
NIC = Number of-infected cultures
NUC = " " uninfected cultures
CIN = Cumulative infected
CUN = Cumulative uninfected
FIN = Fraction infected
%IN = Percent infected
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1.4. Electron Microscopy Studies on Producer Cells
1.4.1. Introduction
The viabilities of cultures of B958 and QIMR-WIL 
producer cell lines were determined by the Trypan blue 
exclusion test. Cells from cultures which were >
viable were suspended in freshly prepared CM (3 x 10  ^ cells/ 
ml). After 9 days incubation at 37°C, cell pellets were 
collected by centrifugation at 350 xg for 20 mins. The 
pellets were fixed, dehydrated, sectioned, and observed 
by electron microscopy (EM) as detailed in Section 4 
(Methods).
A 200 mesh with 100 squares was used on EM grids. 
Approximately 25 squares, (20 cells/square) were 
investigated from 10 samples of pellets of B95# or QIMR-WIL 
cultures. Therefore, for each producer cell line, approx. 
5,000 cells were investigated.
1.4.2. Discussion
Figs. 2-7 illustrate and summarize typical electron 
micrographs which were observed. In Fig. 2, E = viral 
envelope.
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Fig. 2 Structure of Encapsidated EBV Particle
capsid
DNA core
(Magnification x 81, 000)
%
1 1 0
Fig. 3. Partially disrupted B958 Cell 
Encapsidated forms of EBV B958 can be seen in 
the cytoplasmic matrix of the partially 
degenerated cell.
T = tubular structure (Kitamura e_t , (1978))
E = Early stage in the replication of Herpes­
viruses, showing viral capsid with bar 
(Friedmann e_t , (1975))
(Magnification x 39,000).
w
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Fig. 4.' Degenerated form of QIMR-WIL Cell 
Many empty capsids can be seen in the nuclear 
and cytoplasmic matrices of the cell. Arrows 
in Fig. represent extracellular forms of EBV 
QIMR-WIL. The encapsidated DNA cores are 
early stages in the replication of Herpes­
viruses. (Magnification x 20,050).
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Fig. 5. Partially Disrupted form of QIMR-WIL Cell 
Arrows indicate various forms of encapsidated EBV 
QIMR-WIL. Two forms of EBV QIMR-WIL (large arrows 
in the cytoplasmic matrix) are seen with the viral 
DNA filaments not completely within the viral 
capsids. Ringed arrow indicates an encapsidated, 
barred, form of EBV QIMR-WIL. (Magnification 
X 39,000).

116
Fig, 6, Undisrupted form of B958 Cells 
The plasma membranes of B958 cells have not 
been disrupted after 9 days of cultivation. 
Two encapsidated EBV B95B particles are seen 
attached to the cell on the right.
Attachment of the viral particles to the 
cell could be proceeding penetration of the 
cell. (Magnification x 66,000).
m%
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Fig. 7. Extracellular forms of EBV B958 
A viral DNA filament is seen partially 
encapsidated on the surface of a B958 cell 
(top, left). Many encapsidated forms of EBV 
B958 are evident. Two capsids are seen with 
5 DNA cores encapsidated, suggesting >1 EBV 
(B958) DNA core can become encapsidated in 
the capsids of EBV B958 particles. 
(Magnification x 40,050).
■ :sa
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1.5, Population Doubling Times for EBV-transformed
Cells
1.5.1. Introduction
EBV B95B and EBV QIMR-WIL transformed cells were main­
tained in culture for 4 (-SAM78, -EIF7B) or 6 (-IM77,
-RK77) months after the establishment of the transformed]
state. The viabilities of the pairs of cell lines were : 
determined by the Trypan blue exclusion test. Culturesjof 
cells which were 90-93^ viable, were suspended in CM (lOyO 
mis) at 3-3.5 x 10 cells/ml - although the densities varied, 
care was taken to ensure that each pair of cell line had 
been suspended at similar densities. The cell suspensions 
were duplicated for each cell ]ine in tissue culture flasks 
(25 cm^) and incubated at 37°C.
Samples (200 were removed from each cell suspension
at the following times after incubation : - i
0, 15, 24, 39, 47, 62 and 70 hrs. '
Clumps of cells were gently disrupted before each.sample was 
taken and the viability of the sample determined by the 
Trypan blue exclusion test.
1.5.2. Calculation of Population Doubling Times :
Discussion
The data in Fig. B represents log^^ No, of cells at ; 
time t (hrs) after infection. Each point on the graph 
represents an average of 4 cell lines - the culture for
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each cell line was duplicately sampled. Regression lines 
were determined and the slopes of the graphs calculated vj 
according to the method of Bishop (1978), The slopes of' 
the lines were determined to be 0.12 for B9 and QW trans­
formed cell lines. This suggested that the growth rate's
were similar for both groups of cell lines. j
{'
The growth rate constant (k) for each cell line was); 
determined mathematically, by making use of the following 
formula (Paul, 1975) ;
LogioNt - Log^^N^
0.301t
where : ^°SlO*t " ^^^10^0 = ^lope of line
hog^^Ng = No. of cells at time 0 hrs. 1=
|;
Log^^N^ = No. of cells at time t hrs. |
t = 47 hrs; 0.301 = growth
rate factor, i
The population doubling time X = l/k hrs. !
The averages of X for QW transformed cell lines which 
had been maintained in culture for 4 and 6 months were 
26.52 and 27.72 hrs respectively. The averages of X for 
B9 transformed cell lines which had been maintained in
1:
culture for 4 and 6 "months were 29.39 and 28,60 hrs |
I '
respectively : - I
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B9 transformed QW transformed
Cell Line 
*B9SAM78 
*B9EIF78 
B9IM77 
B9RK77
X (hrs) 
34.48
24.29
27.29 
29.41
Cell Line 
*QWSAM78 
*QWEIF78 
QWIM77 
QWRK77
X (hrs) 
22.73 
30.30 
24.39 
31.25
* Maintained in culture for 4 months.
Raji (6HAT25DC), B958 and QIMR-WIL were subjected to 
the same experimental conditions as described in the 
Introduction of this section. The populations’ 
doubling times were determined for each of the cell lines.
X was found to be consistently 22.7, 21.4, and 32.6 hrs 
for Raji, B958, and QIMR-WIL cell lines respectively.
X for the 4 B9 and QW transformed cell lines were 
determined to be 28.87 and 27.18 hrs respectively.
There was no statistically significant difference 
observed between X for cultures of B9 or QW transformed 
cells which had been maintained in culture for 4 or 6 
months after establishment of the transformed state, or 
between pairs of B9 and QW transformed cell lines. X was 
therefore a stable factor among producers (B958, QIMR-WIL), 
restringently infected (Raji) and EBV-transformed HUCLs.
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1.6. Population Densities of EBV-transformed Cell Lines
1.6.1. Introduction
B9 and QW transformed cell lines were maintained in
culture for 7 or 5 months after the establishment of the
transformed state. The viabilities of cultures were 
determined by the Trypan blue exclusion test. Cell 
cultures which were >90% viable were suspended in CM (3-3.5 
X 10 cells/ml); pairs of cell lines were suspended at 
similar densities. Samples (200 jul) were removed from 
duplicate culture flasks (for each cell line under test) 
over a period of 10 days at the following time intervals
0, 1, 2, 3, 4, 5, 7 and 10 days.
The viability of each sample was determined - before
sampling, clumps of cells in suspension were disrupted.
The population densities (Pds), were determined at the time
of sampling each cell line. Table 1.3 displays the
maximum population densities (P ) which were attained ^ ' max
and the time (t , in days (d)) at which.P was attained' \ / max
for each cell line.
1.6.2. Discussion
Among B9 transformed cell lines, the averages of P' max
5for 5 and 7 month-old cultures were 14.66 and 13.36 x 10
cells/ml respectively. Among QW transformed cell lines,
the averages of P for 5 and 7 month-old cultures weremax
19.75 and 20.34 x 10^ cells/ml respectively. Older
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cultures of B9 transformed cell lines therefore had 
fractionally lower, while older cultures of QW transformed 
cell lines had fractionally higher densities than newly , 
established cultures.
Among B9 and QW transformed cell lines, for 11
pairs of cell lines were 14.07 - 0.94 and 19.01 - 1.16 x 10 
cells/ml respectively. P^^^ were attained on : -
2(1), 3(7), 4(3) and 3(4), 4(7) days
respectively for B9 and QW transformed cell lines - where 
the numbers in brackets represent the number of cell lines.
QW transformed cell lines had longer life span in culture 
than B9 transformed cell lines, thus acquiring a capacity 
to attain higher population densities.
Raji (6HAT25DC), QIMR-WIL, and B958 cell lines were 
suspended in freshly prepared CM (3 x 10^ cells/ml) and 
subjected to similar experimental conditions as detailed! 
in 1.6.1. of this section. The growth patterns of the 
producer cell lines were represented graphically (Fig. 9). 
Averages of the Pds which were attained at each time Interval 
for the 11 pairs of cell lines which had been investigated, 
were also represented graphically on Fig. 9 :■ Pd (number 
of cells X 10 /ml) against t (days).
B958 cells survived for a much longer period of time 
in culture than QIMR-WIL cells. QIMR-WIL cells on the 
other hand, reached higher P^^^ (30 x 10^ cells/ml) than 
B958 cells (26.2 x 10 /ml). Raji (6HAT25DC) consistently
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Table 1.3. Population Densities of EBV-transformed 
Cell Lines
B9
Cell Line P
Transformed
T(d)
QW Transformed
Cell Line P  ^ (xlO^/ml) max T(d)
*B98AM78 16.6 3 *QW8AM78 20.2 4
*B9ELB78 13.1 2 *QWELB78 14.4 3
*B9EIF78 15.8 3 *QWEIF78 19.3 4
^B9MAC78 13.6 3 *QWMAC78 22.8 4
*B9AMR78 8.7 3 *QWAMR78 18.3 4
*B9L0C78 20.2 4 *QWL0C78 23.5 4
B9FL77 13. 5 3 QWFL77 ' 20.9 3
B9AW77' 11.0 4 QWAW77 22.6 3
B9RK77 ■ 15.3 3 QWRK77 23.7 4
B9AB77 13.0 4 QWAB77 14.4 4
B9SD77 14.0 3 QWSD77 . 20.1 3
%-
Cell lines maintained in culture for 5 months 
after establishment of the transformed, state - 
other cell lines were maintained for 7 months.
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had P at 25,8 x 10 cells/ml, suggesting that P once max f j <=><=> to max
acquired was a stable feature of the cell line, under
consistent experimental conditions. Holly (1975) suggested
that P in vitro could be a measure of tumourgenicity in max —  ------ —
vivo. j^Tiax consistently attained on the fourth day
after incubation for Raji and QW transformed cells. QW
transformed cell lines could therefore represent populations 
of EBV-transformed cells which are nearer to the tumour- 
igenic state than B9 transformed cells, in terms of. 
proliferative capacity.
The fact that B958 survives for a much longer period 
of time in culture would suggest that an advantageous 
characteristic is conferred on monolayer cultures like 
B958. The fact that most EBV-transformed LCLs in culture 
proliferate as clumps of cells, would suggest that cell 
clumping could be an alternative to the adherence 
phenomenon of monolayer cultures, for survival dm vitro; 
Degeneration of the culture could be associated with loss 
of adherence or cell clumping capacities.
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F ig . 9 Growth patterns of EBV-transformed
Cells
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1.7. Summary
Encapsidation of Herpesviruses occurs within the 
nuclei of infected cells. Assembly of the viral DNA 
occurs in the nuclei and passes from the nucleoplasm 
into the preformed capsid, via pervious pores in the 
capsids (Friedmann _ejt a_l. , (1975)). Envelopment of the 
encapsidated particle occurs as the viral particle passes 
from the nucleus to the cytoplasm for subsequent release. 
Envelopment is a feature of Herpesviruses hut is not a 
prerequisite for the release of viral particles.
Many EBV B958 particles were seen in the extracellular 
matrices with complete hexagonal EBV (B958) DNA cores.
On the other hand, most EBV (QIMR-WIL) DNA cores which 
were observed in electron micrographs were incomplete.
In Fig. 5 (large arrows) partially encapsidated forms of 
EBV QIMR-WIL were evident. In Fig; 2., an enveloped, 
cytoplasmic form of EBV QIMR-WIL was evident, which would 
suggest that EBV QIMR-WIL do become enveloped on occasions. 
Envelopment of encapsidated EBV QIMR-WIL is probably a pre­
requisite for the release of fully encapsidated, hexagonal, 
EBV (QIMR-WIL) DNA cores. On the other hand, envelopment 
of encapsidated EBV B958 is probably not a prerequisite 
for the release of fully encapsidated forms of EBV (B958)
DNA cores.
Henderson e_t a^. , (1977) found that marmoset lymphocytes 
were 1,000 times less sensitive to EBV (B958) transformation 
than HUCLs. Yet, Miller e_t al., (1973) obtained the high
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transforming EBV B958 strain by passaging EBV 883-L in 
B958 cells. The fact that more than one EBV (DNA) core 
can become encapsidated in EBV particles could contribute 
to the high transforming efficiency of EBV B958. The 
next stage in these studies would be to analyze the 
extracellular forms of EBV 883-L, for comparison with the 
extracellular forms of EBV B958, EBV B958 could be a
mutant strain of EBV 883-L which reverts to the wild type
with lower transforming potential in marmoset cells.
The transforming efficiencies of EBV B958 and EBV 
QIMR-WIL were found to be 10^ ^nd 10^*° TD^^/ml 
respectively. The time lapse between infection and 
establishment of the transformed state for pairs of B9 
and QW infected cells were found to be 12,8 - 0.5 and
24.2 - 1.5 days respectively. The lower TE for EBV
QIMR-WIL, therefore influenced the longer time lapse 
which was observed between infection and establishment 
of the transformed state among QW infected cells.
'Chapter 2 
Immunological Features of 
EBV-transformed Cells
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2.1. EBV-associated Antigens In Pairs of Transformed 
Cell Lines.
2.1.1, Introduction
The 16 pairs of B9 and QW transformed cell lines 
were maintained in cultures for 3-5 months after the 
establishment of the transformed state had been determined. 
The viabilities of cultures from 2 day-old cultures were 
determined by the Trypan blue exclusion test (Methods,
2.2)o Smears were prepared from cultures which were >90% 
viable by cytocentrifugation (Methods, 2.2).
EBNA was detected by the anticomplementary immuno­
fluorescence test on acetone/methanol-fixed smears (Methods, 
9.4)o Smears of cells from cultures and suspensions of 
Raji, BJAB and uninfected HUCL preparations were prepared 
and tested as positive and negative controls for EBNA. 
(EBNA)^ cells were regularly detected among Raji but never 
among BJAB or uninfected HUCL preparations. EA or VGA was 
detected by direct IF test on acetone-fixed smears (Methods, 
9.3.3). Smears from Raji and P^HR-1 cultures were used as 
negative and positive controls respectively in the direct 
IF test for the detection of EA and VGA positive cells.
EA and VGA positive cells (2-3%) were always detected 
among P^HR-1 but never among Raji cells.
The percentages of EBNA, EA and VGA positive cells in 
each of the 16 pairs of cell lines were determined 
(Methods, 9.1). Photographs of smears of cells which 
were treated for the detection of EBNA and E A, were taken 
with high speed Ektachrome 400 film (Kodak) with u.v.
1 3 2
illumination (Figs. 10-15). The patterns of fluorescence 
were similar between EA and VGA positive cells.
2,1.2. Synthesis of EBNA Among Pairs of Gell Lines
All 16 pairs of cell lines which had been B9 and QW 
transformed, synthesized EBNA (Table 2.1). 81.7 - 97.6%
and 88.5 - 97.6% were (EBNA) among QW' and B9 transformed 
cells respectively. The average percent (EBNA)* cells 
among the 16 pairs of cell lines were 91.6% and 89.88% for 
B9 and QW transformed cell lines respectively.
The maximum population densities (P ) among B9' max
transformed cell lines were attained on the third day after
subculture. On the other hand, P for most QW trans- ^ max
formed cell lines tested (Section 1.6, Results) was 
attained on the fourth day after subculture. EBNA is at 
its maximal level among EBV-transformed cells during late 
G^/early S^ phases of the cell cycle (Slovin , (1980);
Ernberg e_t aA. , (1977)). EBNA detection was carried out 
among both B9 and QW transformed cells on the second day 
after subculture. The fractional differences which were 
observed between the (EBNA)* cells of B9 and QW transformed 
cell lines (Table 2.1), most probably reflected the different 
stages in the cell cycle, among the two groups of cell 
populations.
The pattern of fluorescence among (EBNA)* cells 
varied from finely granular to brightly staining. The 
pattern of fluorescence was similar between pairs of cell
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Table 2.1 EBV-assoc lated Antigen Positive Cell Lines
B9 Transformed 
Gell Lines
QW Transformed 
Gell Lines
Gell Line % Positive Cells 
for
EBNA EA VGA
Gell Line % Positive 
for
EBNA EA
Cells
VGA
B9SD77 94.1 - - QWSD77 87.2 - -
B9FL77 89.7 - - QWFL77 85.1 - -
B9MM77 92.8 - - QWMM77 87.6 - -
B9RK77 88.5 1.4 - QWRK77 95.8 - -
B9EL77 90.6 1.6 - QWEL77 85.6 0.3 -
B9IM77 92.4 ” - QWIM77 82.1 — -
B9AW77 97.6 - “ QWAW77 '90.2 -
B9AB77 90.1 “ - QWAB77 93.0 - -
B9ELB78 89.1 - — QWELB78 88.1 - -
B9EIF78 92.0 - - QWEIF78 84.8 - -
B9SAM78 96.2 0.8 - QWSAM78 81.7 - -
B9BEB78 92.1 - - QWBEB78 94.7 - -
B9L0C78 88.9 0.4 0.2 QWL0G78 95.7 — -
B9MAC78 89.7 - - QWMAG78 96.1 - -
B9EIB78 93.8 - - QWEIB78 97.6 - -
B9AMR78 89.2 - - QWAMR78 92.8 — -
Abbreviation positive cells not detected.
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lines which had been obtained from one pool of HUCLs 
(Figs. 10 and 11) as well as between pairs of cell lines 
which had been obtained from dissimilar pools of HUCLs 
(Figs. 12 and 13).
2,1.3. Producers Among Newly Established Cell Lines
EA was detected as a diffused component of (EA)* cells 
(Figs. 14 and 15). 4 cell lines (B9RK77, B9EL77, B9LOC78
and B9SAM78) which had been B9 transformed, synthesized EA. 
On the other hand, only one cell line (Q,WEL77) which had 
been QW transformed, synthesized EA. One pair of cell 
line, -EL77, synthesized EA, But, the percentage of EA 
synthesizing cells among B9EL77 population, was 5.3 times 
higher than the percentage EA synthesizing cells among 
QWEL77 population (Table 2.1, columns 3 and 7).
One cell line (B9L0C78) which had been B9 transformed, 
had 0.4% (VGA)* cells. On the other hand, neither QWL0G78 
or any other QW transformed cell population, synthesized 
VGA. The percentage (EA)* cells among B9L0G78 population, 
was twice as many as the percentage (VGA)* cells.
B9 transformed cell lines therefore had higher numbers 
of producers among the 16 pairs' of cell lines, than QW 
transformed cell lines. The kinetics of EA and VGA 
production was investigated.
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2,1.4. Kinetics of EA and VGA Production
Gells from a culture of QIMR-WIL producer cell line 
which was >90% viable, were suspended in 50 ml freshly 
prepared GM (3 x 10 cells/ml) in sterile 100 ml conical 
flasks (x2). The cell suspensions were incubated at 37°G 
and samples (5.0 ml) were removed every 24 hrs on the 
following days after incubation
0, 1, 2, 3, 5, 8 and 10.
Smears were prepared from each sample by cytocentrifugation, 
treated for the detection of EA and VGA positive cells 
(Methods, 9.3.3) and the percentages EA and VGA positive 
cells determined from each smear (Methods, 9.1).
The percentages EA and VGA positive cells were found 
to increase with the time of incubation, and reached a 
maximal level on the second day after incubation of the 
cultures as indicated below : -
Time (days) 0 1 2 3 5 8 10
% EA* Gells 3.5 4.7 6 . 5 3.1 2.0 0.6 0.6
% VGA* Gells 1.9 2.2 2.5 1.8 0.0 0.0 0,0
Among producers, maximal EA and VGA syntheses were therefore 
achieved on the second day after subculture.
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Fig, 10, (EBNA)* cells among QW-transformed 
cells, QWSD77 : prepared by the anticomplementary
immunogluorescence test (Methods, 9,4) and il
photographed with Ektachrome 400. I
(Magnification x 40).
Fig.' 11. (EBNA)* cells among B9-transformed " 
cells, B9SD77 : prepared by the anticomplementary
immunofluoresence test (Methods, 9.4) and 
photographed with Ektachrome 400.
(Magnification x 40).
•M
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Fig, 12, (EBNA) cells among QW-transformed 
cells. QWMM77 : prepared by the anticomplementary
immunofluorescence test (Methods, 9.4) and 
photographed with Ektachrome 400. ;
(Magnification x 40).
Fi'g. 13. (EBNA)* cells among B9-transformed 
cells, B9ELB78 : prepared by the anticomplementary
immunofluorescence test (Methods, 9.4) and 
photographed with Ektachrome 400.
(Magnification x 40).
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Fig.' 14. (EA)* cells among QW-transf orme d
cells, QWEL77 : prepared by direct IF
(Methods, 9.3.3) and photographed with 
Ektachrome 4OO, (Magnification x 25).
Fig. 15. (EA)* cells among B9-transformed
cells, B9RK77 : prepared by direct IF
(Methods, 9.3.3) and photographed with 
Ektachrome 4OO. (Magnification x 100)
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2,2. Ig Positive Cells Among Newly Established Cell
Lines.
2.2.1. Introduction
The 16 pairs of cell lines were maintained in culture 
for 3-5 months after the transformed state had been 
established. Cell suspensions (>90^ viable) from 2 and 3 
day-old cultures were subjected to the direct IF test for 
the detection of clg^ (Methods, 9,3.2) and sig* (Methods, 
9 .3.1) cells respectively,
sig cells were detectable mainly as discontinuous 
fluorescent rings (Fig. 16), The immunofluorescence of 
clg* cells varied from detectable to bright (Fig, 17).
The percentages of sIg and cig cells were determined for 
the 16 pairs of cell lines.
2.2.2. Results and Discussion : Ig^ Cells Within
Cell Lines.
The averages of the percentages Ig cells were 
determined as indicated
Ig Type For 
B9 transformed QW transformed
y. Y k . X u Y k X
sig'*' 19.2 6.3 13.2 3.6 11.5 3.5 7.7 3.5
olg'*' 12.1 2.6 4.7 4.4 3.7 1.3 1.4 1.5
*}-
The averages for the percent slg{y) and slg(Y) cells 
among B9 transformed cells were 19.2 and 6.3, but 11.5 and
143
3.5 among QW transformed cells. The ratios of the percentages 
slg(pt)*'' : 8lg(y)^ cells among B9 and QW transformed cells 
were 3,0 : 1.0 and 3.3 : 1.0 respectively. The percentages
+ _ _ / V +of slgiy) and slgty) cells among B9 transformed cells
therefore exceeded those among QW transformed cells.
However, the ratios of the percentages of slgC/i)**” : slg(y)’*' 
cells among B9 and QW transformed cells, approximated 
equality.
The percentage slg(k)* cells among B9 transformed cells 
exceeded those among QW transformed cells. On the other 
hand, the percentages slg(X)^ cells among both groups of 
transformed cells were similar. Among B9 and QW trans­
formed cells, the percentages slg(k)* cells exceeded the 
percentages slg(X)* cells. The ratios of slg(k)* : slg(X)* 
cells were found to be 3.7 : 1.0 and 2.2 : 1.0 among B9 
and QW transformed cells respectively.
The ratios of clg(^^* : clgfy)* cells were; 4.7 : 1.0 
and 2.7 : 1.0, among B9 and QW transformed cells respectively. 
The ratios of B9 : QW transformed cells for cXg()L*)^ : clg(y)* 
cells were; 3.3 : 1.0 and 2.0 : 1.0 respectively. The 
percentages clg(^)* cells therefore exceeded the percentages 
clgty)* cells among B9 and QW transformed cells. The
percentages clgC/i)*^ and clg(y)* cells among B9 transformed 
cells, exceeded those among QW transformed cells.
The percentages of clg(k)* and clg(X)* cells among B9 
transformed cells, exceeded those among QW transformed cells. 
The ratio of the percentages clg(k)^ : clg(X)’* cells was
1.1 : 1.0 among B9 transformed cells. Among QW transformed
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cells, there was a slight imbalance in the ratio of 
olg(k)^^ : clg(X)**' cells (0.9 : l.O) in favour of clg(X)*** 
cells.
The numbers of Ig"*" (both slg^ and clg^) cells among 
B9 transformed cells therefore exceeded the numbers of Ig 
cells among QW transformed cells.
Among both B9 and QW transformed cell lines, the 
percentages and distributions of sig cells exceeded those 
for cIg cells among Igs y? k and X positive cells.
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Fig. 16. sig cell among QW-transformed 
cells, QWAW77 : prepared by direct IF
(Methods, 9.3.1) and photographed with 
Ektachrome 400. (Magnification x40).
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F ig . 17 Fluorescence of Immunoglobulin 
molecules within the cytoplasm s of 
EBV-transformed cell line QWEIB78: 
detected by FITC-RAH Ig (g)_Ig_type^  
in the direct IF Technique
(Magnification x 40)
O cigcig
cig
cig
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2,2.3. Distribution of sig Cells Among Cell Lines 
Fig. 18 : A Cell lines with slg(^)* cells
" slgCy) "
" slg(k)* "
" Blg(X)* "
No, of cell lines with %age sig cells 
detected by Ig type for 
B9 transformed QW transformed
Li V  k  X u Y k
Range : 0 - 5 7 1 13 2 12 8 12
n : 5 _ 10 2 5 4 1 6 4 2 3
" :10 - 15 3 2 6 1 3. 3 1
" :15 - 20 3 2 3 1 4 3
" :20 - 25 5 2 1
" : 2 5 - 30 1
'» :30 - 35 2
The numbers of cell lines with and sIg(k)* cells.
were distributed over a wider range than those with sig( y )*^
and slg( X) cells respectively. among both B9 and QW transf
cell lines. The numbers of cell lines with 8lg(^0*, slg(y )
and slg(k)^ cells among B9 transforme d cell lines, were dis
tributed over a wider range than those among QW transformed
cell lines. However, the ranges of cell lines with s
cells, approximated equality among B9 and QW transformed cell 
lines.
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F ig. 1.3 F re quency distribution of sig cells among LCLs
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2.2,4. Distribution of cig Cells Among Cell Lines
Fig, 19 : A = Cell lines with clg(pj* cells
B = ti ti It clg(y)* ”
C It ti If clg(k)* ”
D + ” " ” clg(X)* "
N o . of cell lines with %age cig’*' cells
detected by Ig type for
B9 transformed QW transformed
Y k X Y . ^ 4
Range : 0 - 5 1 13 8 8 14 16 16 16
" : 5 -10 7 3 8 8 2
" :10 -15 2
" :15 -20 4
>' :20 -25 2
" :25 -30
" :30 -35
The numbers of cell lines with clg(^j* cells were distri-
buted over a wider range than those with clg(Y)* cells, among
B9 and QW transformed cell lines. However, the numbers of
cell lines with clg(k)* and clg(X)^ cells, were confined to
similar ranges among both B9 and QW transformed cell lines.
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F ig . 19 Frequency distribution of cig cells among LCLs  
1 i EBV (B958) transformed cell l in e s  
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2.3. Producer Cell Lines Among Long-term Cultures
2.3.1. Introduction
B9 or QW transformed : -EL77, -L0C78, -IM77 and 
B9 transformed; B9RK77, B9ELB78 cell lines, were main­
tained in culture for 18-20 months after the establishment 
of the transformed state. Using anti-EBV antiserum, F^- 
Esther, the percentage (EA)* cells was determined for each 
cell line (Methods, 9.3.3). The percentages sig and cig
cells were also determined (Methods, 9.3.1 and 9.3.2). 
The three parameters were then compared as illustrated in 
Fig. 21.
2.3.2. Discussion
-IM77, B9ELB78 and QWL0C78 cell lines which were 
(EA) 3-5 months after establishment, were found to be 
(EA)*, 18-20 months after establishment.
The percentage clg(^)^ cells in B9ELB78 cell 
population was found to be higher among long-term (21.3%) 
than among short-term (8.3%) cultures. The percentages 
8lg(/i)’* cells were found to be similar among long-term 
(20.8%) and short-term (23.2%) cultures. The corresponding 
QW transformed cell line, QWELB78, was subjected to the 
direct IF test to detect the percentages slg(pj* and clg(^)**' 
cells. QWELB78 was found to have increased percentages of 
both sig and cig (^)* cells. 5 months after establishment, 
the percent sig and cig (p^* cells were 16.9 and 2.7, but 
36.6 and 26.0 respectively, 20 months after establishment.
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B9 and QW transformed cell lines -IM77 and -L0C78 
similarly had higher percentages of clg(p)*** cells among 
long-term, than among short-term cultures. The percent­
ages slg(^j* cells between short-term and long-term 
cultures varied as indicated below :~
Cell Line % Ig Cells after Time of Establishment
3-5 months 18-20 months
8lg(p)* clg(M)^ slg(/^)* clg(^)*
B9IM77 20.7 9.1 10.6 22.3
QWIM77 7.4 4.9 13.0 16.8
B9L0C78 16.8 0.4 9.0 13.2
QWLOC78 12.9 3.8 28.0 24.6
Among long-term .cultures of -IM77, B9ELB78 and QWL0C78 
populations of EA(D) synthesizing cells were selected for 
continual proliferation. Among long-term cultures of -IM77, 
41,0078 and -ELB78, populations of cells with high percent­
ages of clg(^j* cells were selected for continual 
proliferation.
The percentages (EA)* cells among B9L0G78 and QWEL77 
were similar between 3-5 and 18-20 month-old cultures.
The percentages (EA)* cells among B9E177 and B9RK77 
populations were found to be lower among 20 month-old than 
among 5 month-old cultures.
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The percentages clg(;i)* cells were higher among long­
term than among short-term cultures, for B9 and QW 
transformed -EL77. On the other hand, the slg(^) cells 
varied between increased and decreased percentages in 
long-term and short-term cultures, as indicated in Fig. 21. 
The percentages sig and cig (/:)* cells among B9RK77 
populations, were found to be the same in long-term and 
short-term cultures (Fig. 21). The corresponding QW 
transformed cell line, QWRK77 was subjected to the direct 
IF test for the detection of cig and sig (p)* cells.
Among QWRK77 cell population, the percent slg(pt)* and clg(/^) 
cells in short-term culture were 15.7 and 6.6, but 35.6 
and 13.4 in long-term cultures, suggesting that, QWRK77 
had increased percentages of cig and sig (p,)* cells.
While the percent slg(^)’*' cells fluctuated between 
increased and decreased percentages, the percentages clg(ju)* 
cells were higher among long-term than among short-term 
cultures for both B9 and QW transformed cell lines.
Long-term cultivations of EBV-transformed HUCLs therefore 
had increased percentages of Ig synthesizing cells, 
irrespective of the viral strain which induced trans- 
f ormation.
2.4. Summary.
Populations of EBV-transformed cells which were (EA)” 
in short-term cultures, were found to be (EA)* in long­
term cultures. Among the populations of cells, the 
percentages of clg(^)* cells were found to be higher in
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long-term than in short-term cultures. On the other hand, 
slg(/i)* cells varied between increased and decreased per­
centages in long-term and short-term cultures. The 
possibility therefore existed that, among cultures of 
EBV-transformed cells, Ig synthesis was a consequence of 
EBV-associated antigenic stimulation.
Ig, EA and other translational products of EBV- 
transf ormed cells have been found to occur at specific 
stages of the cell cycle (Fig. 22). EBV-transformed
cells in culture can therefore be used to elucidate the 
processes of gene expression in B-cells, with or without 
antigenic stimulation (Fig. 22).
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^ig-22 Some translational products of the EBV 
transformed cell
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3.1. Immunoglobulin Production in Long-term Cultures
3.1.1. Introduction
Pairs of B9 or QW infected cell lines; -IM77, -ELB78,
-SD77 and -RK77, were maintained in culture over a period
of 20 months after establishment. Cells were taken from
2 day-old cultures and the viabilities of the populations
determined by the Trypan blue exclusion test. Cultures
which were >90% viable, were labelled biosynthetically
with ^^8-methionine (B9 and QW -RK77) or ^H-leucine (B9
6
and QW -IM77, -ELB78 and -SD77) with 100 ^Gi/4 x 10 cells 
for each cell line (Methods, 12.1). The labelled intra­
cellular and secreted proteins were collected. The Ig 
proteins were precipitated from the samples with RAH 
antisera against y, (Table 3, Methods), Y, k and \ (Miles) 
classes and subclasses with GAR IgG as described in 
Methods; 12.2,, 4., and 7.. Reduced samples (30 yl/ 
sample well) were electrophoresed (Methods : 13.1 - 4), 
fluorographs prepared and processed as described in Methods; 
13.5., and 6. All fluorographs were exposed for 42 
(^H-leucine label) or 21 (^^S-methionine label) days.
The data is represented in Figs, 23 - 26.
Abbreviations : -
a /s = RAH antibody type
T/N = Track number; except in Fig. 23 (Analysis of
of'QWELB7S),
odd Nos. = intracellular (IN)
Ig proteins 
even Nos. = secreted (SD)
Ig proteins
161
X in Fig. 25 = L(k) precipitated from Bec-11 cells. 
H,L ( ) = Heavy or light chain type.
3.1.2. Synthesis of Ig(H) chains in Long-term cultures
20 month-old cultures synthesized and secreted Ig(/i) 
among both B9 and QW transformed cell lines 
-ELB78 : Fig. 23; T/Ns 1 and 5
-RK77
-SD77
-IM77
Fig. 24 
Fig. 25 
Fig. 26
T/Ns 1 and 2 
T/Ns 1 and 2 
T/Ns 1 and 2
On the other hand, Ig(y) was not detectable among 20 
month-old cultures of B9 and QW transformed cell lines :-
■ELB78
•RK77
■SD77
■IM77
Fig. 23 
Fig. 24 
Fig. 25 
Fig. 26
T/Ns 2- and 6 
T/Ns 3 and 4 
T/Ns 3 and 4 
T/Ns 3 and 4
The rate of turnover for Ig(/i) synthesis was greater among 
B9 transformed cell lines; B9ELB78, B9RK77, B9SD77 and 
B9IM77. This observation was evidenced by the much s h a r e r  
bands which were observed among intracellular and secreted 
y chains of the B9 transformed than among the corresponding 
QW transformed cell lines (Figs.. 23 - 26),
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3.1.3. Synthesis of Ig(L) Chains in Long-term Cultures
One pair of cell lines in long-term cultures (-RK77), 
was found to synthesize L(k) but not L(X) : -
Fig. 24 : T/Ns 1, 2, 5 and 6 
On the other hand, B9 and QW transformed cell lines 
-SD77, -IM77 and -ELB78 synthesized L(A) but not L(k) as 
indicated below
QWELB78
B9ELB78
-SD77
QWIM77
B9IM77
Fig. 23 
Fig. 23 
Fig. 27 
Fig. 26 
Fig. 26
T/Ns 1 and 4 
T/Ns 1 and 7 
T/Ns 2 and 8 
T/Ns 2 and 8 
T/Ns 2, 7 and 8
The long-term cultures of B9 and QW transformed cell 
lines; -SD77, -IM77, -RK77, and -ELB78 were subjected to 
the direct IF test for the detection of cig and sig, (k)* 
and (A)* cells (Methods, 9.3.1 and 9.3.2).
While Ig(k) was detected, Ig(A) was not detected in 
the cytoplasms or on the surfaces of B9RK77 and QWRK77 
cells. On the other hand, Ig(A) was detected, but Ig(k) 
was not detected in the cytoplasms or on the surfaces of; 
-SD77, -IM77, and -ELB78 cells. Among the above pairs of 
cell lines, there was therefore an imbalance between Ig(k)*^ 
and Ig(A)* cells in favour of Ig(A)* cells.
Within pairs of cell lines, similar light chains were 
synthesized in long-term cultures. There was undoubtedly 
a selection of Ig( A) synthesizing cells above Ig(k)^ 
synthesizing cells among B9 and QW transformed -SD77,
-ELB78 and -IM77. Barandun et al., (1976) similarly
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found that, among pairs of maternal and umbilical cord 
blood samples, there was an imbalance of the equality of 
Ig(k) and Ig(X) in favour of Ig(A). It is therefore
probable that among certain neonatal lymphoid cell 
populations, there is a selection of Ig(X) above Ig(k) 
light chain type.
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3.2. Distribution of I g Synthesizing Cells Among
Lymphocyte Populations
3.2.1. Introduction
Samples of blood were collected from human umbilical 
cords, or the peripheral blood of subjects of varying ages 
(in most cases, 3 samples for each age study). Heparinized 
blood (20 i.u./ml) was subjected to Ficoll-hypaque density 
gradient centrifugation (Method, 5.3) and mononuclear cells 
collected. Using FITC-conjugated RAH antisera which had 
been raised against ^ , y , k and A heavy and light chain 
types (Behring), the mononuclear cells were subjected 
to the direct IF test (Methods, 9.3.1).
Mononuclear cell populations were collected from the 
spleens and livers of Balb/c mice of varying ages, by 
Ficoll-hypaque density gradient centrifugation. The 
viabilities of the cell suspensions' were determined by the 
Trypan blue exclusion test (Methods, 2.2). The densities 
of the suspensions were determined with white cell 
counting fluid (Methods, 5.3.1). The cells were then 
subjected to the indirect methods of IF (Methods, 9.5),
The patterns of fluorescence of sIg cells among 
untransformed human lymphocyte populations was similar to 
Fig. 16. The pattern of fluorescence of sig* cells 
among murine lymphocyte populations is displayed in 
Fig. 26A.
The percentages of sig (k)* and (A)* cells among 
murine lymphocyte populations as well as the percentages
169
Fig. 26A. Murine spleen lymphocyte 
(sig*) : prepared by indirect IF
(Methods, 9.5) and photographed with 
Ektachrome 4OO, (Magnification x lOO)
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8lg {(x) (y) (k)* and (A)* cells among human lymphocyte
populations were determined.
3.2.2. Distribution of Ig Classes Among Normal 
Human Lymphocyte Populations
The percent 8lg(^)* and slg(y)* cells among untrans­
formed HUCL populations were found to be 21.3 and 6.5, 
but 15.1 and 12.5 respectively among untransformed 
lymphocyte populations which had been obtained from young 
adults (20-25 yrs).
The percentage slg(^i)* cells was found to decrease 
with age (Fig. 27). Between 0 and 10 yrs, there was gross 
fluctuation, with increases and decreases among Ig(jLi) 
synthesizing cells. This fluctuation probably reflected 
the post-natal increase of Ig(ju) synthesizing cells, as well 
as the response of Ig synthesizing cell populations to 
antigenic stimulation. Between 10 and 20 years, Ig(^)* 
cells remained at similar numbers, but higher than the 
numbers of Ig(y) synthesizing cells. Ig(/2)"*" cells 
approximated equality with Ig(y) synthesizing cells between 
20 and 30 years,
3.2.3. Distribution of Ig Subclasses Among Murine 
Lymphocyte Populations
The percent slg(A)* and slg(k)* cells at birth (>24 hrs 
old), were 2.81 and 2,26 respectively, among lymphocyte 
populations which had been obtained from the spleens of
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Balb/c mice. Among lymphocyte populations which had been
obtained from the livers of newborn mice, slg(A)* cells 
similarly showed a slight dominance over slg(k)* cells. The 
percent slg(X)* cells was found to be 2.3, while the percent 
slg(k)* cells was found to be 2.01.
+
Ig(k) cells increased with age among murine lymphocyte 
populations (Fig. 28). At birth, the percentage Ig(k)* 
and lg(X)* cells approximated equality. The percentage 
slg(k)* and slg(A)* cells increased between 0 and 7 days 
after birth. However, there was a much sharper increase 
in the numbers of slg(k)* cells than among slg(A) cells 
during this period of time. While slg(k)* cells continued 
to increase after age 7 days, there was no significant 
increase in the percentage slg(A)* cells after age 7 days. 
The percentage slg(X)* cells between 7 days and 15 weeks, 
approximated equality.
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3.2.4. Development of Ig(k) Dominance Among Murine and 
Human Lymphocyte Populations
The ratios of the percentages slg(k)* and slg(X)* cells 
were determined among human (Fig. 29) and murine (Fig. 30) 
lymphocyte populations.
The development of Ig(k) dominance among murine and 
human lymphocyte populations were found to occur in 3 phases 
as indicated below
humans : phase 1 = G-5 yrs approx.
phase 2 = 5-20 " "
phase 3 = 20 years onwards.
mice : phase 1 = 0-3 days approx.
phase 2 = 3 - 9 ” "
phase 3 - 9  days onwards.
The response of Ig synthesizing cells to antigenic 
stimulation among human lymphocyte populations was 
determined. Blood samples were taken from human donors 
with various pathological symptoms (Table 3.1), and 
subjected to the direct IF test (Methods 9.3.1).
While the percentages of 8lg(^J* and slg(y)* cells 
fluctuated between ages 0-24 years in response to various 
pathological conditions, the ratios of slg(k)* : slg(X)^ 
cells existed in 3 distinct phases. These phases were 
similar to those among "normal” subjects. This suggested 
that Ig(k)^ cells responded preferentially to antigenic 
stimulation above Ig(X)* cells during the developing stages 
of humans (and most probably mice).
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Table 3.1. Ratios of sig Cells in Relation to 
Pathology of Donor
Age of Donor 
(years)
+
Ratios of sig 
fi: y( 1.0)
Cells 
k:X(l.O)
Pathological
Complaint
0.0 3.3 1.05 HUCLs
1.2 8.0 1.05 Bronchitis
1.5 3.4 1.04 Congenital heart 
disease
3.0 1.5 1.04 Recurrent chest 
infections
5.0 4.0 1.04 Epilepsy
7.0 4.Ô 1.07 Cystic fibrosis
9.5 6.0 1.37 Diabetic
10.0 2.2 1.33 Congen.'£ tal 
cardiac failure
20.0 1.9 1.28 Influenza
24.0 1.1' • 1.60 It
GENERAI DISCUSSION
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Lymphoblastold cell lines (LCLs) have been established 
from patients with IM and BL (Pagano _et aj.. , (1976);
Epstein , (1965)). LCLs have also been established
by the transformation of lymphocytes vitro by EBV 
(Katsnki 2Ï sj.. ^ (1975)). The cells which are susceptible 
to EBV infection, have been shown to bear surface immuno­
globulin and have Fc as well as C ’3 receptors (sIg*Fc^(B)- 
cells; Jondal e_t a_l. , (1973)). While BL-derived LCLs 
have been shown to be sIgM positive (Klein e_t , (1968)), 
other populations of EBV-infected (B)-lymphocytes have 
been shown to be polyclonal in nature (Rosen aj^ . , (1977))
Among the 16 pairs of cell lines which had been trans­
formed by EBV B958 and EBV QIMR-WIL, both IgM and IgG were 
detectable in the cytoplasms as well as on the surfaces of 
most cell lines which had been maintained in culture for 
3-5 months after the establishment of the transformed 
state had been determined. Katsuki e_t aj^ . , (1977) found 
that the frequency of ÉBV-transformed HUCL populations and 
sIgM positive cells not only correlated, but had similar 
values. They suggested that sIgM positive cells were 
the target cells for EBV-induced transformation among 
HUCL populations. However, in the system which was 
employed by Katsuki e_t _al.. , (1977), the only monospecific 
antiserum which had been used, was directed against Ig(pt) 
heavy chain type. Yamamoto e_t aj_. , (1976) established 22 
EBV-infected LCLs from tonsilLar lymphocytes which had 
been obtained from children of varying ages. They showed 
that eight of these 22 cell lines produced cytoplasmic IgA,
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Steinitz e_t aJ.. , (1980) preselected and successfully EBV- 
transformed slg(A) positive lymphocytes from HPB and 
lymphocyte populations which had been obtained from NPC 
patients. These findings strongly suggest that sig 
positive cells, other than sIgM positive cells are indeed 
susceptible to EBV-induced transformation. It is a
■f" -f-
probability that all sig Fc B-cells are susceptible to 
EBV-induced transformation. The populations of B- 
lymphocytes which are susceptible to EBV-induced trans­
formation vitro are most probably dependent on the 
population of Ig synthesizing cells vivo (Steel ejfc a l ., 
(1977)).
Katsuki ejb , (1975) found that IgG and IgM could 
be detected in the cytoplasms of newly transformed EBV- 
infected HUCL populations of cells. However, they found 
that slgM but not sIgG could be detected among populations 
of EBV-transformed HUCLs. The failure of Katsuki e_t a l . ,
(197 5) to detect sIgG positive cells, could have been due 
to the age (4-5 months old) of the cultures which had been 
tested for the detection of sIgG positive cells. Secondly, 
a smaller number of cell lines (6 pairs) were investigated 
by Katsuki e_t , (1975) .
Among long-term cultures of EBV (B958) and EBV (QIMR- 
WIL) transformed cells, IgM but not IgG synthesizing cells 
could be detected among HUCL populations. This finding 
agrees favourably with those of Evans _et a^. , (1974) 
and Steel _et a_l, , (1977), The percentages of IgM 
synthesizing cells among normal human lymphocyte 
populations, were found to vary with age. At birth, the
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ratio of IgM ; IgG synthesizing cells was 3.3 : 1.0;
4.8 : 1,0 at age 2y years, hut decreased» to 2.2 : 1.0 at 
age 10 years. Between the ages of 10 and 20 years, the 
ratios of the percentages of IgM : IgG synthesizing cells 
were 2.2 : 1,0 and 2.3 : 1.0 respectively. The percent­
ages of IgM synthesizing cells approximated equality with 
IgG synthesizing cells after 20 years of age. The percent­
ages of IgM positive cells therefore exceeded the 
percentages of IgG synthesizing cells among lymphocyte 
populations which had been obtained from infants. Among 
lymphocyte populations which had been obtained from 
adolescents, there was a fractional difference between the 
percentages of IgM and IgG synthesizing cells, in favour 
of IgM synthesizing cells. James e_t , (1974) similarly 
found that in children (<10 years old) the percentages of 
lymphocytes which bore sIgM were greater than those which 
bore sIgG. Among lymphocyte populations which had been 
obtained from adults, James ejb a_l. , (1974) found that the 
percentages of lymphocytes which bore IgG and IgM, approx­
imated equality.
The occurrence of high titre heterophile sheep cell 
agglutinins which occur during IM has been well documented. 
All available evidence indicates that these antibodies are 
exclusively 198 (IgM) in nature (Wollheim ejt n l . , (1966)). 
The fractional difference between IgG and IgM synthesizing 
cells among adolescents could possibly account for the 
proliferative response of IgM synthesizing cells among 
adolescents who contract IM,
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The development of Ig(k) dominance was found to 
exist in three phases among lymphocyte populations which 
had been obtained from human donors. The ratio of the
percentages of Ig(k) : Ig(X) synthesizing cells was found
to be constant at equality between the ages of 0 and 5 
years, but increased between 5 and 20 years in favour of 
lg(k) synthesizing cells, Ig(k) synthesizing cells 
maximized after age 20 years. The development of Ig(k) 
dominance was similarly found to exist in three phases 
among mouse lymphocyte populations. The ratios of the
percentages of Ig(k) ; Ig( X) synthesizing cells were found
to vary between approximately 0.9 : 1.0 and 2.9 : 1.0 
between 0 and 3 days respectively, but 3.5 : 1.0 at 9 days 
after birth. There was a further increase in the ratio of 
Ig(k) : lg(X), in favour of Ig(k) synthesizing cells between 
9 days and adulthood (15 weeks). Haughton ejb a^., (1978) 
similarly found that among lymphocyte populations which had 
been obtained from mouse spleens, the dominance of Ig(k) 
synthesizing cells, developed as a function of age.
They suggested that the predominance of Ig(k) synthesizing 
cells in adult mice had been established by an antigen- 
driven clonal expansion of the repertoire of Ig(k) genes 
which expanded as a function of age. Hood ejb aJL. , (1967) 
suggested that there is an evolutionary relatedness between 
the genes which controlled the synthesis of Xg(k) subclasses 
among human and mice species. They found that, 60^ of the 
amino acid residues which had been obtained from humans and 
mice Ig protein subclass Ig(k) constant region proteins,
were similar in their sequence distributions. If the
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development of the dominance of Ig(k) synthesizing cells 
(consequently the gene pools which control Ig(k) synthesis) 
among human lymphocyte populations exist in three phases, 
it is therefore not surprising that the development of 
lg(k) dominance among murine lymphocyte populations 
(consequently the gene pools which control Ig(k) synthesis), 
should similarly exist in three phases.
Among lymphocyte populations which had been obtained 
from donors with various pathological disorders, the ratios 
of the percentages of IgM : IgG synthesizing cells were 
found to vary. The ratios of the percentages of Ig(k) : 
Ig(X) synthesizing cells among these subjects were found 
to exist in three phases which were comparable with normal 
subjects. Among lymphocyte populations which had been 
obtained from one donor (1 year old) who had bronchitis, 
the ratio of IgM : IgG synthesizing cells was 8.0 : 1.0. 
Among lymphocyte populations which had been obtained from 
one epileptic donor (5 years old), the ratio of the percent­
ages of IgM ; IgG synthesizing cells was 4,0 : 1.0.
However, the ratios of the percentages of Ig(k) : Ig(X) 
synthesizing cells which had been obtained .from the subjects 
at 1 and 5 years were constant at approximately 1.0 : 1,0. 
The ratios of the percentages of IgM : IgG synthesizing 
cells among -lymphocyte populations which had been obtained 
from one subject with cystic fibrosis (7 years old), was
4.8 ; 1.0, but 2.2 : 1.0 among lymphocyte populations which
had been obtained from one subject who had congestive heart 
failure (10 years old). The ratios of the percentages of
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Ig(k) : Ig(X) synthesizing cells was 1.1 : 1.0, hut 1.3 :
1,0 among lymphocyte populations which had been obtained 
from subjects at 7 and 10 years respectively. Among 
lymphocyte populations which had been obtained from two 
subjects (20 and 24 years) who had influenza, the ratios 
of the percentages of IgM : IgG synthesizing cells were
1,9 : 1,0 and 1,1 ; 1.0 respectively. The ratios of the 
percentages of Ig(k) : Ig(X) synthesizing cells among 
subjects at 20 and 24 years, were 1.3 : 1.0 and 1.6 : 1.0 
respectively.
These findings would agree favourably with the 
suggestion of James _et £l*^ (1974), that the elevated 
numbers of lymphocytes bearing IgM early in life, is 
replaced with age and/or antigenization, by lymphocytes 
bearing IgG. Secondly, the development of the light chain 
type kappa dominance among Ig synthesizing cells may also 
reflect maturation and/or antigenization.
Burkitt's lymphoma is primarily a childhood disease with 
a peak incidence at age 5 years (Burkitt, (1962)). From 
the foregone data, it is conceivable that age 5 is crucial 
in terms of the utilization of the gene pools which direct 
Ig syntheses among Ig synthesizing cells. This situation 
could predispose subjects with a depressed immune system 
(e.g. among malarial subjects) to EBV-induced oncogenesis 
in vivo.
BL-derived LCLs in culture almost always synthesize 
IgM heavy chain class (Fialkow _et a_l. , (1973); Klein _e^ al. ,
(1968)), The decrease in the preponderance of IgM
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synthesizing cells with age, and the association of BL 
with infants in particular and juveniles in general, 
obviously contribute to the dominance of IgM synthesizing 
cells among BL-derived LCLs, The ratio of the percentages 
of IgM : IgG synthesizing cells among untransformed HUCL 
populations was found to be 3.3 : 1.0. The ratio of the 
percentages of IgM : IgG synthesizing cells among EBV (B958) 
and EBV (WIMR-WIL) transformed cell lines (3-5 months old), 
were found to be 3.0 : 1.0 and 3.3 : 1.0 respectively.
This suggested that IgM synthesizing cells exceeded IgG 
synthesizing cells among untransformed as well as EBV- 
transf ormed HUCLs. Among long-term cultures of EBV 
(B958). and EBV (WIMR-WIL) transformed cells, IgM, but not 
IgG synthesizing cells could be detected. The selection 
of IgM synthesizing cells among long-term cultures of 
EBV-transformed HUCLs was therefore attributable to the 
pool size of the IgM synthesizing cells among HUCL 
populations.
Long-term cultures were found to have higher numbers 
of producers (for EA synthesis) than the corresponding 
short-term cultures. While long-term cultures were found 
to consistently have higher percentages of cytoplasmic IgM 
positive cells, surface IgM positive cells fluctuated be­
tween increased and decreased percentages. Wollheim et. al., 
(1966) suggested that one mechanism for the formation of 
the heterophile antibody among IM patients could be that 
EBV shares antigenic determinants with IgM. Tovey ejb , 
(1978) found that anti-IgM antibody could induce the
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synthesis of EA in Raji cells. The induction of EA in 
Raji cells was Ig(|i) specific since antisera to : Ig(k), 
Ig(X), IgA, IgE and IgD were not effective in inducing the 
synthesis of E A . Among long-term cultures of EBV- 
transformed HUCLs, Ig(gJ was not only detectable on the 
surfaces and in the cytoplasms of transformed cells, but 
was also secreted into the extracellular growth medium as 
detected by SDS-polyacrylamide gel-electrophoresis, It 
is therefore highly probable that the released Ig(p) chains 
induced the synthesis of EA among established cultures of 
EBV-transformed cells. Furthermore, one cell line which 
had a decrease percentage of EA synthesizing cells during 
long-term cultivation, showed no difference in the 
percentages of cytoplasmic or surface Ig positive cells 
between short-term and long-term cultures.
The numbers of IgM, IgG, Ig(k) and Ig(X) positive 
(both sig and cl g positive) cells among EBV (B958) trans­
formed cells, exceeded the corresponding numbers of Ig 
positive cells among EBV (QIMR-WIL) transformed cells. 
Similar findings were observed by Katsuki jejt a^. , (1975) - 
these workers did not observe or compare the frequency of 
Ig(X) synthesizing cells among EBV (B958) or EBV (QIMR-WIL) 
transformed cells. These findings strongly implicate 
the possibility that EBV (B958) transformed cells had
-f- -f-
higher percentages of differentiated sig Fc B-cells, 
than EBV (QIMR-WIL) transformed cells.
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The time lapse between infection and establishment 
of the transformed state was found to be longer among 
EBV (QIMR-WIL) infected, than among EBV (B958) infected 
cultures of cells. The transforming efficiency of EBV 
B958 was found to be higher than the transforming 
efficiency of EBV (QIMR-WIL). The higher transforming 
efficiency of EBV B958 could account for the shorter time 
lapse between infection and establishment of the trans­
formed state among EBV (B958) infected cultures of cells. 
However, the possibility cannot be eliminated that 
undifferentiated B-cells are less subject to EBV-induced 
transformation. Consequently, EBV (QIMR-WIL) infected 
cells would require a much longer period of time for the 
establishment of the transformed state than EBV (B958) 
infected cells.
The application of these studies to the study of the 
control of the immune system cannot be overlooked. If 
EBV (B958) and EBV (QIMR-WIL) transformed cells represent 
different percentages of differentiated B-cells it is not 
difficult to envisage that different Ig responses should be 
observed during mimicry of the immune response vitro 
among these two groups of cells. Kishimoto jet a l .,
(1978) have described the mimicry of the immune response 
in vitro among established LCLs of various origins. If 
different Ig responses are observed following the induction 
of EBV (B958) and EBV (QIMR-WIL) transformed cells after 
T-cell stimulation (Kishimoto _et a_l., (1978)), this would 
undoubtedly present a system for the study of B-cell
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differentiation _iii vitro. Since Ig and non-Ig synthesiz­
ing, EBV-transformed cells vitro represent Ig and non- 
Ig synthesizing cells vivo (Steel e_t a_l, , (1977)), 
the studies could then he related to B-cell differentiation 
in vivo.
Work is in progress to identify the Major Histocompat­
ibility Complex alloantigenic markers which are bOY'nc . on 
the pairs of EBV (B958) and EBV (QIMR-WIL) transformed cells
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FACTORS GOVERNING THE EXPRESSION OF EBV-.ASSOCIATM) DISEASES 
There is no doubt that the special availability of 
appropriate target cells, host immunological capacity and 
genetically determined characteristics are factors which 
govern the type of symptoms which are expressed among individ­
uals who contract EBV,
BL is commonly observed in areas of Africa (Burkitt, 1958), 
New Guinea (Ten Beldam et I966), and less commonly in the
United States (Ziegler et al.. 1976) and Europe (Bomlcarm et. al 
1976). Although sex ratio and age-grouping show remarkable 
similarity between New Guinean and African BL, there has been no 
distinct geographical and climatic limitations observed in New 
Guinean BL as seen in African BL, It therefore seems highly 
probable that an environmental factor could be associated with 
African BL to allow this distinct geographical and climatic 
distribution to be displayed.
The fact that BL is most common in malarial endemic areas 
of Africa would implicate malaria as the contributory environ­
mental factor which is associated with African BL, Malaria is 
a powerful stimulator of the reticuloendothelial system and 
constant onslaught on the cells of this system in malarial- 
endemic areas might provide the correct host environment to 
bring about malignant transformation. Children with acute malaria 
have been shovm to have a diminished antibody response to certain 
antigens. Greenwood et al.* 1972 found that among children in 
Gambia in which malarial prophylaxis was being canned, out, there 
was a greater antibody response to tetanus toxoid than in children 
in which malarial prophylaxis was not being carried out. Persis­
tent malaria could therefore act as a cofaotor by stlraulatinig and 
maintaining a continuing large supply of lymphoid cells, especially 
liable to undergo malignant change in response to infection by the 
virus,
Where BL is endeniic in Africa, almost the entire population 
is infected by EBY at an early age (Henle £t , 19&9) and hyper- 
endemic malaria affects over 50% of young children. Yet, only 
small numbers of these doubly infected individuals develop the 
tumour. It seems likely, that, in addition to an environmental 
factor, a genetic predisposition to BL could also exist, Fialkow
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et aie, I97O; 1975 found that BL is of monoclonal origin. How­
ever, there is as yet, no evidence which would point to a genetic 
predisposition to BL as observerd among HPC subjects.
Infectious Mononucleosis
IM only occur in individuals without antibodies to EBV, since 
all pre-illness sera available by chance or by design from pro­
spective studies of IM proved to be uniformly devoid of all anti­
bodies to EBT (Henle et al,. 1975)» The disease is rare in persons 
over 35 years old-i.e., in age ranges in which over 80% of indi­
viduals possess antibodies to EBV (Henle ^  al*, I966), Yoshida 
et al., 1980 found that antibody titres to VGA among randomls'- 
selected infants (O - 3 years) and children showed that 35% ef 
infants had acquired antibodies to VGA, All antibodies to VGA 
appeared after 7 months althouugh none developed the symptoms of 
IM. IM is primarily associated with adolescents and young adults 
because of the large amounts of viral particles obtained on infeo- 
ion during this age group,
Henle ot al., 1970 found that there is a low frequency of 
EB7 infections in children from middle and upper socio-economic 
status, consequently a large number of individuals from these 
groups reach adolescence and early adulthood without contracting 
the virus, IM however, is rare among Africans in young adoles­
cents and yourg adults, Henle £t al,, I969 found that sera which 
had been taken from African children who served as control groups 
(without African BL) showed that EBV is widespread in Africa as 
elsewhere in the world, Primary infections occur in Africa more 
often and early in life. As a result, few individuals reach 
adolescence and early adulthood without detectable antibodies to 
EBV, This explains the rarity of IM among Africans in these age 
groups,
IM is a self-limiting disease - T-cells which specifically 
destroy EBNA-positive cells from EBV-transformed K5L in vitro
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have been demonstrated by Cr-release technique among circulating 
lymphocytes of IM patients during the acute phase of the illness 
(Svedmyr et al,, 1975î Royston et al,. 1975)* In some cases of 
severe immunosuppression e.g., in renal transplant patients, or 
individuals with genetic T-cell defects, anti-EBNA may be undete­
ctable even though VGA-specific IgG antibodies are maintained at 
moderate or even high titres (Henle et al., 1975)*
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The expression and extent of expression of EBV infections 
as IM, BL or NIL! is therefore very distinctly associated with age, 
socio-economic status, the immune status of the host as well as 
probable genetic predispositions to the diseases.
The EBV-susceptible cell(s)
The initial target cells of infection during IM remain to be 
identified. On the basis of in situ hybridization tests with 
exfoliated oropharyngeal epithelial cells from IM patients, Lemon 
e£ , 1977 have claimed that these cells support replication of 
EBV, However, additional evidence is needed to substantiate this 
conclusion.
Among BL subjects, the initial cell for transformation Is 
thought to be a B-lymphocyte. Klein _et al., I966 found that cells 
from the BL-derived LCL Daudi, were slg(p) and slg(v.) positive, 
suggesting that sig positive cells are indoed susceptible to EBV- 
induced transformation, Jondal et al., 1975 have sho\m that 
slg'^ Pc'^  B-cells but not T-cells bear EBV receptors among IM-, BL- 
and other EBV-transformed TGLs as well as cells from HP'B, Tliese 
data strongly point to the involvement of the B celt in EBV-induced 
oncogenesis.
The application of chromosome banding technique to BL- 
and non-BL-derived LGLs has revealed a constant structural abnorm­
ality of chromosome I4 (Manolov et al., 1972; Jarvis et al., 1974)*
' 11 III# 11B wrMiÊmm r r \ (mewwn r '
This abnormality has been shown to be due to a translocation from 
No, 8 chromosome to give an extra band on both long arms of 
chromosome I4, designated t(8q~; 14q+). However, the No, I4 
chromosome has been shown to be particularly unstable, A similar 
abnormality has been found among other types of malignant lymph­
oma e.g., lymphosarcoma, reticulum cell carcinoma, Hodgkin’s 
lyiTphoma, and follicular lymphoma (Fukuhara et al., 1976) as well 
as after in vitro cultivation of lymphocytes which had been taken 
from malignant and non-malignant cases (Beatty-de Sana ef , 1975). 
It could therefore be that, B-cells carrying the spontaneous 
mutation t(8q-; 14q*^ ) increase in number during the lymphoid 
stimulation of chronic malaria.
Infection of a cell of this kind by EBV in malarial cases, brings 
about the transformation event, leading to the production of a
•^(Zech ejt al., 1976)
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clone, expressing EBV-determined nuclear antigens.
The target cell for transformation among NPC subjects is not 
l<no\m, althon^ infiltrating lymphocytes have been found in these 
patients and the EBV DMA has been detected in the epithelial cells 
of the tumour although they are devoid of EBV receptors (Volf ejb 
al., 1975). The role of the infiltrating lymphocytes could be 
the involvement in the imnrune response against antigens which are 
specified by the virally-transformed cell.
Tonigaki £t al., 1976 established LCLs from the peripheral 
blood leukocytes of myelogenous leuîcaeraia. They found that some 
cells had the appearance of immature plasma cells a^d EM revealed 
that their structure was similar to that which was characteristic 
of plasma cells, No microscopic characteristics have been found 
by Moore at. I968 which separate cultured human lymphoblastoid
cells which had been derived from seropositive individuals and 
from patients with leukaemia, BL or IM,
Integration of EBV genome
Integration of the linear EBV BNA is thought to occur 
between 0 and 3 days after infection (Epstein et al,, 1979)* The 
mechanism for integration is not fully defined but a model has been 
proposed (Epstein et al., 1979)* Modification of the linear EBV 
DBA is thought to occur prior to integration and there are specific 
host attachment sites on each DBA molecule which are available for 
integration. The substrate BNA for integration is covalently 
closed, double-stranded and supercoiled, Supercoiling may alter the 
secondary structure of attachment sites and thus render them 
accessible for the enzymes catalyzing the Integration event. 
Exonucleases are then involved to generate the sticky ends, which 
promote the circularization of the molecule (Kintner et al,, 1979).
EBV Strains and EBV-associated Diseases
The resident EBV DMA in HPC tumour cells, BL-derived tumour 
cells and lymphoid cells which have been obtained from IM patients 
occur partly as free episomes and partly as integrated sequences 
(Kaschlca-Bierch at al.. 1976; Lindhal ^  , 1976; Adams ^  &1*,
1975» Pagano et al,, 1975)* There is therefore no difference in 
principle, between the way in which the viral genome associates 
with the BHA of a BL, an HPC or a lymphoid cell which has been 
derived from an IM patient„
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Recently, Bornlcamia et al.. I98O analysed, the EBV BNA fragments which 
had been isolated from BL-derived P^ER-1 and 0034-5? IM-derived 
B958? HPC-derived M-ABA and myeloblastic lexilcaemia-de rived Q,IFiR- 
\TÏL LCLs, with restriction endonucleases. They found that :~
(I) all strains studied were closely related
(II) the number of internal repeat sequences was variable
among and within viral strains
(III) EBV B95& was the only strain with a large deletion of 
about 10,000 base pairs at the right-hand side of the 
molecule. At the same site, small deletions of about 
4OO-5CC base pairs were observed in EBV P^HR-1 and 
EBV M-ABA DNAs.
(tv) EBV P^HR-1, the only non-transforming EBV strain, had
a deletion of about 30O-4OO base pairs,
(V) small inserted sequences of 15O-40O base pairs were
observed in M-ABA and EBV (B95&) BNAs,
(VI) the cleavage patterns of •P^ HR-1 virus DNA and the
results of blot hybridizations with P^HR-1 virus frag­
ments were not■conclusive and pointed to the possibility 
that in addition, some viral sequences may be arranged 
differently.
Although it is possible therefore that small differences in 
the genome organization of EBV may have significant biologic 
effects, the great similarity among different EBV strains does not 
favour the hypothesis that disease-specific subtypes exist,
FimCTXONAL CHANGES AND EBV-TRAH8P0EMED CELLS 
Immunoglobulin Production
V/hether or not EBV-transformed B-cells possess antibody 
activity against available common antigens is within dispute.
Earner e£ , I968 reported that cells of the Bl^-derived cell line 
P^J, produced Ig proteins which suppressed plaque formation by 
bacteriophage T^* On the other hand, Krueger et al., 1974 could 
not find any significant neutralizing activity which would suggest 
that P^J had anti-T^ activity. Steel et , 1974 have presented 
evidence, though unconfirmed, which would suggest that the proli­
feration of EBV-transformed LCLs in vitro may be responsible for 
the production of agglutinins which are directed against fixed 
sheep red blood cells (SRBC),
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Induction of specific antigens can be brought about under 
appropriate in vitro conditions with EBV-transformed lOLs» Luzzati 
et al*, 1977 found that, by adding 8BB] and EBV-infected BPBLs to 
an £1 vitro system, EBV-transformed cells were obtained with anti- 
SRBG antibody activity. Similarly, Steinitz e£ al,, 1977 succeeded 
in establishing EBV-transformed cells which produced anti-hapten 
(anti-WNP) antibody from a population of surface anti-hapten 
antibody-carrying lymphocytes, which had been preselected from 
non-antibody expressing cells by resetting with BMP-coated eryth­
rocytes, It is therefore probable that most specific antibodies 
can be induced with EBV-transformed cells under specific environ­
mental conditions,
Lymphokine 3
The supernatant fluid recovered after stimulation of 
sensitized lymphocytes with antigen possess activity some of which 
have been ascribed to different molecular species. Among them 
are:-
(I ) macrophage migration inhibition factor ,(HIE) which 
discourages the migration of macrophages from the site 
of antigen-mediated lymphokine release
(I I ) lymphotoxin which has marked cytotoxic activity and is 
thought to be associatted with inhibition of tumour 
growth
inhibition(s) of lymphocyte blastogenesis
The production of lymphokines have been shovm to be a 
functional characteristic of EBV-transformed LCLs (Papageorgiou 
^  al., 1974; Granger et al,, 1970), Granger et al,, found that 
26 of 59 EBV-transformed IGLs produced lymphotoxin, Han et al,, 
1975 found that, inhibitory effects of cell-free supernatants 
from EBV-transformed LCLs on blastogenesis was significantly 
higher than that of supernatants from T-lymphocytes or from 
non-neoplastic cells.
The B-cell might not be the only cell which is susceptible 
to EBV-induced transformation, since NPC-derived epithelial cells 
have been shown to habouY the EBV-BNA, However, the evidence 
which has been presented to date has shown conclusively that the 
B-cell is the only cell type which bears the EBV receptor.
Additional Discussion
Using-the experimental conditions which have been outlined 
in this thesis, transformation was recognized by a change in the 
morphology of the infected cells from small mononuclear cells to 
cells with blastoid morphology, Hhen in suspension as single 
cells. EBV (B95S) transformed cells were found .to be larger than 
EBV (QIMR-T.VTL) transformed cells. EBV- (q,IM-V/IL) transformed 
cells on the other hand, could adhere to culture flasks while 
EBV (B958) transformed cells were non-adherent, Moore et al,.
1968, found that among cultured EBV-transformed cells which had 
been derived from seropositive individuals or from patients with 
leulcaemia, BL or IM, characteristic morphological differences 
could not be recognized. Katsulci et al., 1975 on the other hand 
found that HUCLs which had been transformed by tv/o different 
strains of EBV, 'displayed different morphological characteristics 
in suspension. It is therefore highly conceivable that different 
strains of EBV can induce different morphological characteristics 
in infected cells, depending on the age of the donor - HUCLs 
being more susceptible to morphological variations than BPBLs,
Transformation in the system, which was used for this 
thesis could also be recognized by the appearance of the EBV- 
induced antigen, EENA. The appearance of EBNA was first observed 
on day 2 after infection. Other workers (Thorley-Lawson et al., 
1978; Aya et al., 1974? Yata et al., 1975) have shown that EBNA 
is first detectable between 0 and 3 days after infection. 
Integration of the viral genome is thought to occur between 0 and 
3 days after infection of EBV (Epstein et al,, 1979). It is 
therefore probable that integration of the viral genome into the 
host's chromosome is a necessary prerequisite for EBNA expression 
and the time of expression of‘ EEHA is dependent on the time of 
integration of the infecting viral genome, A consequence of 
integration of the viral genome is the direction of synthesis of 
EBNA, Continual synthesis of EBNA then maintain transformation 
at the translational level.
There is no evidence to date which would suggest that 
EBV-infected cells are induced to synthesize Ig, once transforma­
tion has been initiated. In fact, Steel £t al,, 1977 have pur­
ported that the Ig synthesizing cells among EBV-infected cells are 
the Ig synthesizing cells in vivo. TTie findings of Lazatti et al,, 
1977 and Steinitz et_ al,, 1977 would suggest that in the presence
of appropriate antigens EBV-susoeptible cells could be induced 
to synthesize Ig in response to these antigens. Among long-term 
cultures of EBV (B958) and EBV (QIMR-V/IL) transformed cells, I 
found that, populations of EBV-transformed cells had higher 
percentages of Ig synthesizing cells when compared with those 
among short-term cultures. These populations of EBV-transformed 
cells were thought to be synthesizing Ig in response to EBV- 
induced antigenic stimulation, since populations of cells with 
high percentages of EA-positive cells paralleled populations with 
high percentages of Ig synthesizing cells*
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